Data / Research funding / Peripheral Neuropathy
Peripheral Neuropathy: 783 NIH awards ($844.9M) to 225 organizations
783 NIH awards ($844.9M) in the NIH spending category Peripheral Neuropathy, to 225 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 783 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $19,316,294 | January 1, 2021 | July 31, 2026 | FAVA, MAURIZIO | reporter.nih.gov |
| Site-Directed RNA Editing of Nav1.7 as a Novel Analgesic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,194,636 | September 23, 2021 | August 31, 2027 | ROSENTHAL, JOSHUA J.C. | reporter.nih.gov |
| Human Nociceptor and Spinal Cord Molecular Signature Center | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $9,264,871 | September 19, 2022 | August 31, 2027 | PRICE, THEODORE J. | reporter.nih.gov |
| Sensory Phenotyping to Enhance Neuropathic Pain Drug Development | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $7,081,684 | September 21, 2023 | August 31, 2028 | FREEMAN, ROY | reporter.nih.gov |
| Unravelling Mechanisms and Novel Therapeutic Targets for Peripheral Neuropathy and Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,767,963 | December 15, 2017 | November 30, 2025 | WOOLF, CLIFFORD J | reporter.nih.gov |
| Mechanisms of Action of Peripheral Nerve Stimulation for the Treatment of Chronic Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $6,522,833 | September 20, 2023 | August 31, 2026 | HAH, JENNIFER | reporter.nih.gov |
| Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy | NIH | National Cancer Institute | 2021 to 2025 | $6,132,390 | May 6, 2021 | April 30, 2027 | KOLB, NOAH ALLAN | reporter.nih.gov |
| Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $5,575,218 | September 1, 2021 | August 31, 2025 | SAHN, JAMES JEFFREY | reporter.nih.gov |
| Understanding neural control of the ocular surface | NIH | National Eye Institute | 2022 to 2025 | $5,561,710 | September 30, 2022 | August 31, 2027 | JENKINS, MICHAEL W. | reporter.nih.gov |
| Development of a Potent and Selective Nav1.8 inhibitor for the Treatment of Acute and Chronic Pain with the Goal of Reducing Opioid Use and Preventing Opioid Use Disorders | NIH | National Institute on Drug Abuse | 2023 | $5,341,667 | May 15, 2023 | April 30, 2025 | HUNTER, JOHN CURETON | reporter.nih.gov |
| Optimizing the use of ketamine to reduce chronic postsurgical pain | NIH | National Cancer Institute | 2021 to 2024 | $5,247,593 | September 17, 2021 | August 31, 2025 | WANG, JING | reporter.nih.gov |
| High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,225,127 | January 1, 2025 | April 30, 2025 | MCLAUGHLIN, BRYAN L | reporter.nih.gov |
| Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics | NIH | National Institute on Drug Abuse | 2024 to 2025 | $4,623,799 | September 30, 2019 | December 31, 2026 | CORTES-PUCH, IRENE | reporter.nih.gov |
| Underpinnings of corneal innervation: anatomical, molecular, and functional studies of corneal sensory afferents in physiologic and pathologic states | NIH | National Eye Institute | 2022 to 2025 | $4,440,467 | September 30, 2022 | August 31, 2027 | ROMPOLAS, PANTELEIMON | reporter.nih.gov |
| Genetic Susceptibility and Biomarkers of Platinum-related Toxicities | NIH | National Cancer Institute | 2021 to 2025 | $4,370,186 | September 25, 2012 | June 30, 2027 | TRAVIS, LOIS B. | reporter.nih.gov |
| The biophysics of skin-neuron sensory tactile organs and their sensitivity to mechanical and chemical stress | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,231,127 | December 15, 2017 | September 30, 2026 | GOODMAN, MIRIAM B | reporter.nih.gov |
| STRUCTURAL VARIATION IN NEUROLOGICAL DISEASE | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,141,654 | December 15, 2017 | November 30, 2026 | LUPSKI, JAMES R. | reporter.nih.gov |
| Pain Mechanisms in Fabry Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,085,512 | May 15, 2019 | March 31, 2026 | STUCKY, CHERYL LOUISE | reporter.nih.gov |
| A fully humanized functional genomic screen to identify and validate pain therapeutic targets | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $4,039,366 | September 1, 2025 | August 31, 2028 | PRICE, THEODORE J. | reporter.nih.gov |
| Differentiation of Clinical Phenotypes of Inflammatory and Neuropathic Ocular Pain Conditions with Morphologic Measures and Functional Brain Imaging | NIH | National Eye Institute | 2022 to 2025 | $3,722,281 | September 30, 2022 | August 31, 2027 | MOULTON, ERIC ALAN | reporter.nih.gov |
| Accelerate Clinical Trials in CMT (ACTCMT) Study | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $3,658,507 | May 1, 2019 | February 28, 2026 | HERRMANN, DAVID N | reporter.nih.gov |
| Transspinal Magnetic Stimulation for the Treatment of Neuropathic Pain | NIH | National Institute of Biomedical Imaging and Bioengineering | 2024 | $3,565,780 | September 18, 2024 | August 31, 2027 | BONMASSAR, GIORGIO | reporter.nih.gov |
| Development and validation of a porcine model of spinal cord injury-induced neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $3,560,956 | September 21, 2023 | August 31, 2026 | FLOYD, CANDACE L. | reporter.nih.gov |
| Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system | NIH | National Cancer Institute | 2021 to 2025 | $3,433,365 | July 1, 2021 | June 30, 2027 | BOTA, DANIELA ANNENELIE | reporter.nih.gov |
| Uncovering early signals of hereditary TTR amyloidosis in minority populations at high genetic risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,411,450 | April 1, 2021 | March 31, 2027 | KONTOROVICH, AMY R. | reporter.nih.gov |
| Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,311,688 | March 1, 2021 | February 28, 2026 | FLORIO, STEPHANIE K | reporter.nih.gov |
| Biomarkers of Tissue Tolerance and Behavior in a Rat Model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,262,661 | July 1, 2009 | May 31, 2026 | BARBE, MARY F | reporter.nih.gov |
| Displacement-guided focused ultrasound for pain modulation. | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $3,220,027 | August 21, 2025 | July 31, 2028 | KONOFAGOU, ELISA E. | reporter.nih.gov |
| Probing the biochemical mechanism of amyloid disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,210,642 | May 1, 1993 | June 30, 2026 | KELLY, JEFFERY W | reporter.nih.gov |
| Peripherally-restricted non-addictive cannabinoids for cancer pain treatment | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $3,174,343 | August 1, 2023 | July 31, 2025 | SPIGELMAN, IGOR | reporter.nih.gov |
| Microphysiological Model of Human Cardiac Sympathetic Innervation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,165,021 | July 1, 2022 | June 30, 2027 | KIM, DEOK-HO | reporter.nih.gov |
| Modulation of pain mechanisms by cannabis-derived phytochemicals. | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,150,461 | December 1, 2020 | November 30, 2026 | SETO, TODD B | reporter.nih.gov |
| Clinical Development of SBS-147: First-in-class Oral Arylepoxamide Agonist for Pain | NIH | National Institute on Drug Abuse | 2025 | $3,138,031 | July 1, 2025 | June 30, 2027 | ASHWORTH, JUDY | reporter.nih.gov |
| The glymphatic system at the crossroad of integrative health approaches inchronic pain | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,067,927 | August 1, 2021 | May 31, 2026 | NEDERGAARD, MAIKEN | reporter.nih.gov |
| Accelerating the non-opioid analgesic AFA-281 clinical development with TABA-supported business development | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $3,049,862 | August 1, 2025 | April 30, 2026 | XIE, XINMIN SIMON | reporter.nih.gov |
| Development of a Novel Chemokine Receptor Antagonist Peptide as a Non-Opioid Treatment for Relief of Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,999,505 | September 15, 2021 | August 31, 2023 | RUFF, MICHAEL R | reporter.nih.gov |
| Comprehensive Phenotyping of Specific Populations of Spinal Neurons Processing Cutaneous Information Before and After Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,973,851 | September 16, 2016 | August 31, 2026 | KOERBER, H RICHARD | reporter.nih.gov |
| Development of KLS-13019 for Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,970,772 | September 30, 2021 | August 31, 2025 | BRENNEMAN, DOUGLAS ERIC | reporter.nih.gov |
| Dissection of SARM1-Induced Axon Degeneration and Cell Death | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,966,646 | September 1, 2014 | May 31, 2029 | MILBRANDT, JEFFREY D | reporter.nih.gov |
| A staged, comprehensive investigation for developing insular deep brain stimulation to treat refractory chronic pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,959,839 | September 20, 2022 | December 31, 2028 | ELIAS, WILLIAM JEFFREY | reporter.nih.gov |
| Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement) | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $2,902,023 | September 15, 2019 | June 30, 2025 | HE, ZHIGANG | reporter.nih.gov |
| Characterization of the Properties and Mechanisms of Photobiomodulation-Induced Axonal Block and Evaluation as a Treatment for Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,878,214 | May 1, 2021 | April 30, 2027 | MOFFITT, MICHAEL | reporter.nih.gov |
| Identifying novel therapeutic targets for chronic neck pain: RNA-sequencing in human painful atlanto-axial arthropathy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,872,749 | September 1, 2021 | August 31, 2026 | CURATOLO, MICHELE | reporter.nih.gov |
| Voltage-Gated Calcium Channels in Nociceptors and Mechanoreceptors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,837,880 | August 2, 2006 | July 31, 2027 | LIPSCOMBE, DIANE | reporter.nih.gov |
| Targeting Schwann cell dysfunction and repair signaling in chemotherapy induced painful peripheral neuropathy | NIH | National Institute of Dental & Craniofacial Research | 2024 | $2,833,086 | September 20, 2024 | August 31, 2027 | YE, YI | reporter.nih.gov |
| Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus | NIH | National Eye Institute | 2022 to 2023 | $2,806,822 | September 30, 2016 | July 31, 2023 | COHEN, ELISABETH J | reporter.nih.gov |
| A Self-Tuning Liquid Metal Coil Conforming to Movement for High-Resolution Brachial Plexus MRI | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,775,927 | May 16, 2022 | February 28, 2027 | BALLON, DOUGLAS J | reporter.nih.gov |
| Mechanisms of Pain Associated with Trigeminal Nerve Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,760,934 | August 1, 2021 | June 30, 2027 | GOLD, MICHAEL S | reporter.nih.gov |
| Validation of Prenatal Rabbit Hypoxia Ischemia as a Model of Cerebral Palsy-induced Pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,727,001 | September 19, 2023 | August 31, 2026 | QUINLAN, KATHARINA ANN | reporter.nih.gov |
| Determining the function of medium to large diameter sensory neurons in paclitaxel-induced pain via large-scale in vivo DRG imaging | NIH | National Cancer Institute | 2025 | $2,714,830 | August 6, 2025 | July 31, 2030 | ZHENG, QIN | reporter.nih.gov |
| Study of Activity-Dependent Sympathetic Sprouting | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,675,718 | May 4, 2004 | June 30, 2026 | ZHANG, JUN-MING | reporter.nih.gov |
| Elucidating cutaneous mechanosensory circuits, from development to disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,664,003 | September 1, 2016 | August 31, 2024 | GINTY, DAVID D | reporter.nih.gov |
| Multi-isotope Hybrid PET/CT Imaging of Peripheral Artery Disease in Diabetes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,663,222 | December 19, 2022 | November 30, 2025 | SINUSAS, ALBERT J | reporter.nih.gov |
| The Neurospan Bridge: A Device for Peripheral Nerve Repair | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,594,464 | March 15, 2023 | August 31, 2027 | KOFFLER, YACOV | reporter.nih.gov |
| Anatomic, Physiologic and Transcriptomic Mechanisms of Neuropathic Pain in Human DRG | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,590,497 | April 15, 2020 | February 28, 2026 | DOUGHERTY, PATRICK M | reporter.nih.gov |
| Targeting checkpoint inhibitors for pain control | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,569,851 | September 21, 2023 | August 31, 2026 | JI, RU-RONG | reporter.nih.gov |
| Multi-Omic Biomarkers for Neuropathic Pain Secondary to Chemotherapy | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $2,568,308 | September 30, 2020 | August 31, 2025 | ROTROFF, DANIEL | reporter.nih.gov |
| Evaluation of Small-Fiber Polyneuropathy in Youth | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,545,391 | August 15, 2015 | May 31, 2026 | OAKLANDER, ANNE LOUISE | reporter.nih.gov |
| Effects of Fish Oil ± Salsalate on the Omega-3 Index and the Circulating Lipodome of Omega-3 Polyunsaturated Fatty Acid Metabolites in Patients with Type 2 Diabetes and Diabetic Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,534,893 | February 7, 2022 | January 31, 2027 | YOREK, MARK A. | reporter.nih.gov |
| Metabolic coupling between Schwann cells and axons is functionally distinct from myelination and is disrupted in obesity, prediabetes, and diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,531,361 | August 23, 2022 | June 30, 2027 | FELDMAN, EVA LUCILLE | reporter.nih.gov |
| Development of A Focused Ultrasound Device for Noninvasive, Peripheral Nerve Blockade to Manage Acute Pain | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 | $2,505,537 | September 30, 2023 | September 29, 2026 | ANDERSON, THOMAS A. | reporter.nih.gov |
| New Inactivators of GABA Aminotransferase for Epilepsy and Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,498,237 | July 15, 2021 | June 30, 2026 | SILVERMAN, RICHARD B | reporter.nih.gov |
| Amygdala pain mechanisms | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,469,334 | December 15, 2021 | November 30, 2026 | NEUGEBAUER, VOLKER | reporter.nih.gov |
| Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain with Machine Learning to Predict Treatment Response | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,446,704 | August 1, 2015 | March 31, 2027 | FREGNI, FELIPE | reporter.nih.gov |
| Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,446,165 | September 10, 2020 | June 30, 2026 | WINTERS-STONE, KERRI M | reporter.nih.gov |
| Imaging neuroglial mechanisms of neuropathic pain-opioid interaction in HIV | NIH | National Institute on Drug Abuse | 2021 to 2022 | $2,441,399 | July 15, 2018 | July 31, 2025 | LOGGIA, MARCO LUCIANO | reporter.nih.gov |
| Neuropeptidergic Inhibition of Spinal Pain Transmission | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,433,566 | September 10, 2002 | November 30, 2026 | TAYLOR, BRADLEY K. | reporter.nih.gov |
| Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,424,350 | April 1, 2021 | June 30, 2030 | ZELTNER, NADJA | reporter.nih.gov |
| Immunomodulatory Therapy for Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,420,195 | September 1, 2018 | August 31, 2025 | CHEN, RIDONG | reporter.nih.gov |
| Development of Pathology-activated Drugs for Treatment of Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,408,109 | September 20, 2022 | August 31, 2024 | GRACE, PETER M | reporter.nih.gov |
| A Double-Blind, Randomized, Controlled Trial of Epidural Conus Medullaris Stimulation to Alleviate Pain and Augment Rehabilitation in Patients with Subacute Thoracic Spinal Cord Injury (SCI) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,395,166 | September 15, 2020 | April 30, 2027 | LAD, SHIVANAND P | reporter.nih.gov |
| Disruption of Homeostatic Neuroimmune Interactions in Descending Circuitry in the Development of Pain Chronicity | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,391,373 | July 1, 2020 | June 30, 2026 | WEI, FENG | reporter.nih.gov |
| Axonal transport and chemotherapy induced peripheral neuropathy | NIH | National Cancer Institute | 2022 to 2025 | $2,319,802 | April 1, 2016 | June 30, 2027 | SEGAL, ROSALIND A. | reporter.nih.gov |
| Regulation of Peripheral Neuropathic Pain by B Cells | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,308,227 | March 15, 2022 | February 28, 2027 | GRACE, PETER M | reporter.nih.gov |
| Focused Ultrasound Neuromodulation of Dorsal Root Ganglion for Noninvasive Mitigation of Low Back Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $2,304,494 | September 25, 2019 | August 31, 2025 | RIEKE, VIOLA | reporter.nih.gov |
| Development of MRGPRX1 positive allosteric modulators as non-addictive therapies for neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,299,466 | September 30, 2019 | August 31, 2024 | TSUKAMOTO, TAKASHI | reporter.nih.gov |
| Discovery and Validation of a Novel Response Biomarker Signature for Painful Peripheral Neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,298,698 | September 1, 2022 | April 30, 2026 | NEMENOV, MIKHAIL I. | reporter.nih.gov |
| Exploring the Functions of tRNA Synthetases in the Nucleus and their Relationship to CMT | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,285,535 | April 1, 2020 | March 31, 2025 | YANG, XIANG-LEI | reporter.nih.gov |
| Peripheral and Central Pathways of α3 Glycine Receptors as Non-Opioid Molecular Targets to Treat Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,282,554 | May 1, 2022 | January 31, 2027 | XU, YAN | reporter.nih.gov |
| Link extracellular function of tRNA synthetase with pathological mechanism of disease | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,260,000 | June 1, 2021 | August 31, 2026 | YANG, XIANG-LEI | reporter.nih.gov |
| Elucidating cellular mechanisms underlying neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,259,716 | June 17, 2022 | May 31, 2027 | OPAL, PUNEET | reporter.nih.gov |
| Molecular and Computational Dissection of Cold Nociception | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,254,672 | July 15, 2019 | July 31, 2029 | CYMBALYUK, GENNADY S | reporter.nih.gov |
| Exploring the EphB2-NMDA receptor interaction in spinal cord injury-induced neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,249,630 | September 1, 2018 | June 30, 2029 | LEPORE, ANGELO C. | reporter.nih.gov |
| Validation of neuronal senescence as a target for chronic pain in aging | NIH | National Institute on Aging | 2024 | $2,249,392 | September 15, 2024 | August 31, 2027 | TAWFIK, VIVIANNE L | reporter.nih.gov |
| Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,243,240 | January 1, 2021 | December 31, 2025 | VAN DER BLIEK, ALEXANDER M | reporter.nih.gov |
| The Effect of Medical Cannabis Laws on Health Care Use in Insured Populations with Pain | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,228,671 | July 1, 2019 | April 30, 2026 | ABRAHAM, AMANDA J | reporter.nih.gov |
| Selective Kv7.2/3 activators for the treatment of neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,200,680 | September 1, 2021 | March 31, 2022 | SIGNORE, ARMANDO | reporter.nih.gov |
| Functional and histological changes to peripheral innervation following spinal cord stimulation in patients with painful diabetic neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,189,785 | September 12, 2023 | July 31, 2028 | TOWNSEND, KRISTY L | reporter.nih.gov |
| Supplement to Promote Diversity, Inclusion, and Career Development of a Female Scientist | NIH | National Cancer Institute | 2021 to 2022 | $2,183,954 | December 31, 2021 | August 23, 2023 | ALEMAN GUILLEN, FERNANDO | reporter.nih.gov |
| The role of neuroinflammation in human peripheral neuropathic pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,171,620 | July 1, 2022 | February 28, 2028 | LOGGIA, MARCO LUCIANO | reporter.nih.gov |
| Modulating single cell types in the sensory nervous system | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,152,157 | July 1, 2022 | June 30, 2027 | SCHMIDT, ERIC W | reporter.nih.gov |
| Epigenetic dysregulation in diabetic enteric neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,115,203 | January 1, 2021 | December 31, 2025 | ORDOG, TAMAS | reporter.nih.gov |
| Supplement to Pathogenesis of HIV-associated sensory neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,080,000 | September 30, 2021 | August 31, 2026 | YUAN, SUBO | reporter.nih.gov |
| Development of MMP-9 inhibitory monoclonal antibodies to relieve neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $2,079,796 | August 11, 2025 | July 31, 2027 | GE, XIN | reporter.nih.gov |
| Spinal Cord Nociceptive Circuits that Deliver Outputs to the Brain to Initiate Pain | NIH | National Center for Complementary & Integrative Health | 2023 to 2024 | $2,078,643 | September 15, 2020 | May 19, 2025 | GINTY, DAVID D | reporter.nih.gov |
| Leveraging machine learning to improve risk prediction for chemotherapy inducedneuropathy | NIH | National Cancer Institute | 2021 to 2024 | $2,077,393 | June 1, 2020 | May 31, 2026 | ADAMS, ALYCE SOPHIA | reporter.nih.gov |
| Dissecting the role of mPFC dynorphin circuits in the modulation of different pain states | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,068,842 | September 20, 2024 | August 31, 2027 | SHEETS, PATRICK L | reporter.nih.gov |
| Analytical Validation of Non-native Transthyretin (NNTTR) As A Candidate Biomarker for Transthyretin Amyloidoses (ATTR) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,068,762 | April 1, 2020 | November 30, 2024 | JIANG, XIN | reporter.nih.gov |
| Modulation of the prefrontal cortical network in neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,066,533 | April 1, 2020 | March 31, 2025 | MARTINA, MARCO | reporter.nih.gov |
| Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) Syndrome in the Diabetic, Neuropathic Foot | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,064,907 | March 1, 2016 | June 30, 2028 | HASTINGS, MARY K | reporter.nih.gov |
| Glycosylation in ocular surface health and disease | NIH | National Eye Institute | 2021 to 2025 | $2,064,667 | August 1, 2016 | July 31, 2028 | ARGUESO, PABLO | reporter.nih.gov |
| Interhemispheric Communication and Compensation in Peripheral Nerve Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,062,400 | December 15, 2020 | November 30, 2026 | EGGEBRECHT, ADAM THOMAS | reporter.nih.gov |
| The Genetics of the Neuromuscular Junction: Mechanisms and Disease Models | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,053,330 | August 1, 2025 | May 31, 2027 | BURGESS, ROBERT W. | reporter.nih.gov |
| Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $2,051,325 | September 20, 2023 | July 31, 2025 | KIMLESS, DEBRA | reporter.nih.gov |
| Novel biologic to treat chemotherapy-induced neuropathic pain | NIH | National Cancer Institute | 2022 to 2023 | $2,049,964 | September 19, 2022 | August 31, 2025 | KOGAN, YAKOV | reporter.nih.gov |
| Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients | NIH | National Cancer Institute | 2023 to 2024 | $2,047,415 | September 1, 2023 | August 31, 2025 | ANCHOORI, RAVI KUMAR | reporter.nih.gov |
| Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,042,098 | September 25, 2019 | August 31, 2025 | CHUNG, KEVIN C | reporter.nih.gov |
| Validation of a new large-pore channel as a novel target for neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,039,202 | September 25, 2023 | August 31, 2026 | QIU, ZHAOZHU | reporter.nih.gov |
| The Roles of Neuronal Activity in Peripheral Nerve Myelination | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,036,232 | April 20, 2020 | March 31, 2025 | CORFAS, GABRIEL | reporter.nih.gov |
| A first in class, mechanism-guided, cell-based therapy for complex regional pain syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,033,135 | September 24, 2022 | August 31, 2025 | CHENG, JIANGUO | reporter.nih.gov |
| Mechanism of Nociception Induced by Innocuous Cold in Trigeminal System | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,030,519 | August 11, 2008 | July 31, 2025 | GU, JIANGUO | reporter.nih.gov |
| Selection of a lead LPAR1 antagonist for treatment of diabetic neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,026,502 | May 20, 2021 | April 30, 2025 | BEATON, GRAHAM | reporter.nih.gov |
| Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy | NIH | National Cancer Institute | 2021 to 2022 | $2,000,000 | September 1, 2021 | August 31, 2024 | HANSEN, ANGELA | reporter.nih.gov |
| mHealth app for caregiver instruction in manual therapy for chemotherapy-induced peripheral neuropathy | NIH | National Cancer Institute | 2024 to 2025 | $1,998,767 | August 18, 2022 | May 31, 2026 | COLLINGE, WILLIAM B. | reporter.nih.gov |
| Neuroinflammation in Wallerian Degeneration and Regeneration: Neutrophils Play a Primary Role as Phagocytes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,986,349 | August 1, 2020 | October 31, 2025 | ZIGMOND, RICHARD E | reporter.nih.gov |
| Translating Novel Peripheral Nerve Allograft Technologies Toward Clinical Use | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,980,377 | May 1, 2023 | April 30, 2027 | BITTNER, GEORGE DAVIS | reporter.nih.gov |
| Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain | NIH | National Cancer Institute | 2021 to 2022 | $1,979,001 | September 25, 2019 | April 30, 2025 | SCHWIMMER, LAUREN JENNIFER | reporter.nih.gov |
| Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT)Trial | NIH | National Cancer Institute | 2021 to 2023 | $1,973,105 | December 1, 2020 | November 30, 2023 | BAO, TING | reporter.nih.gov |
| Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress | NIH | National Cancer Institute | 2021 to 2023 | $1,973,060 | September 9, 2019 | August 31, 2024 | LEVINE, JON DAVID | reporter.nih.gov |
| The Role of Cellular Senescence in Carpal Tunnel Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,971,867 | September 10, 2020 | November 30, 2026 | GINGERY, ANNE | reporter.nih.gov |
| Inflammation associated with HIV infection: role of receptor cross-talk | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,971,180 | September 30, 2019 | June 30, 2025 | ROGERS, THOMAS J | reporter.nih.gov |
| Pharmacological validation of adenylyl cyclase 1 as a drug target for chronic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,963,598 | December 1, 2020 | November 30, 2025 | FLAHERTY, DANIEL PATRICK | reporter.nih.gov |
| Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,960,976 | September 30, 2019 | August 31, 2024 | DORN, GERALD W. | reporter.nih.gov |
| Mitofusin Agonists to Treat Neurodegenerative Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $1,954,883 | May 15, 2022 | April 30, 2025 | HAUGER, DEBORAH ANN | reporter.nih.gov |
| Coordination of mucosal immune response to enteric bacterial pathogens by nociceptive innervation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,954,430 | April 1, 2020 | March 31, 2025 | REARDON, COLIN | reporter.nih.gov |
| Lymphotoxin-Beta Receptor Peripheral Signaling Regulates the Transition to Inflammation and Neuropathy-Induced Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,953,071 | May 15, 2020 | March 31, 2026 | AKOPIAN, ARMEN N | reporter.nih.gov |
| Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,940,013 | June 1, 2020 | May 31, 2025 | KATRITCH, VSEVOLOD | reporter.nih.gov |
| Thermal Imaging Modality for Detection of Large and Small Fiber Diabetic Peripheral Neuropathy. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,938,578 | July 1, 2015 | December 31, 2024 | SOLIZ, PETER N | reporter.nih.gov |
| Measuring cellular senescence to predict and prevent peripheral neuropathy | NIH | National Institute on Aging | 2021 to 2023 | $1,928,919 | September 15, 2021 | August 31, 2025 | MITIN, NATALIA | reporter.nih.gov |
| Targeting neuronal transport to ameliorate vincristine neurotoxicity | NIH | National Cancer Institute | 2023 to 2025 | $1,918,934 | July 11, 2023 | June 30, 2028 | HU, SHUIYING | reporter.nih.gov |
| Mechanisms of Axon-Schwann cell interactions | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,913,450 | July 15, 2021 | May 31, 2026 | MONK, KELLY R | reporter.nih.gov |
| CRCNS: Computational Model of Chronic Pain Analgesia via Closed-Loop Peripheral Nerve Stimulation | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $1,909,461 | July 1, 2021 | June 30, 2027 | SARMA, SRIDEVI V. | reporter.nih.gov |
| Imaging Epigenetic Dysregulation in Patients with Low Back Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $1,899,288 | September 26, 2019 | August 31, 2025 | WEY, HSIAO-YING | reporter.nih.gov |
| Multimodal wireless electrical stimulation for tissue regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,893,913 | May 1, 2022 | April 30, 2027 | LI, SONG | reporter.nih.gov |
| Targeting methylglyoxal-induced diabetic neuropathic pain through the integrated stress response | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,890,818 | September 7, 2023 | July 31, 2028 | YOUSUF, MUHAMMAD SAAD | reporter.nih.gov |
| Genomic Studies in Charcot-Marie-Tooth Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,886,243 | September 15, 2019 | July 31, 2025 | ZUCHNER, STEPHAN | reporter.nih.gov |
| Development of LPA5 Antagonists as Analgesics | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,881,741 | July 6, 2023 | June 30, 2025 | ZHANG, YANAN | reporter.nih.gov |
| Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial | NIH | National Cancer Institute | 2021 to 2023 | $1,873,647 | April 1, 2021 | September 30, 2023 | BAO, TING | reporter.nih.gov |
| Molecular Determinants of Synaptic Plasticity in Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,868,197 | August 15, 2017 | November 30, 2027 | PAN, HUI-LIN | reporter.nih.gov |
| Development of Tissue Engineered Neuromuscular Interfaces from GalSafe Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,866,060 | January 15, 2022 | March 31, 2027 | KATIYAR, KRITIKA | reporter.nih.gov |
| Structure and Mechanism of the Kinesin-3 Motor KIF1A | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,865,013 | September 1, 2023 | June 30, 2027 | GENNERICH, ARNE | reporter.nih.gov |
| Allele-specific inactivation for dominant negative NEFL Mutations | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,855,975 | August 15, 2021 | June 30, 2027 | JUDGE, LUKE M | reporter.nih.gov |
| Synergistic Enhancement of Peripheral Nerve Defect Repair using Peptide Functionalized Aligned Nanofiber Conduits | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,840,426 | June 1, 2022 | May 31, 2027 | BECKER, MATTHEW L | reporter.nih.gov |
| Generation of Tissue Engineered Nerve Grafts from GalSafe Porcine Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,835,055 | September 30, 2018 | August 31, 2024 | KATIYAR, KRITIKA | reporter.nih.gov |
| Investigating the Effects of Spinal Cord Injury and Rehabilitative Training on Corticospinal Circuits Controlling Contextual Opioid Analgesic Tolerance | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,829,756 | September 1, 2025 | November 30, 2025 | CAFFERTY, WILLIAM B. | reporter.nih.gov |
| The Gut Microbiome and Serum Metabolites as a Biological Mechanism Underlying Pain in Kidney Transplantation (Biome-KT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,824,012 | May 15, 2023 | February 29, 2028 | LOCKWOOD, MARK | reporter.nih.gov |
| Lipid signaling in supraspinal pain pathways | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,822,223 | April 1, 2020 | March 31, 2026 | SHEETS, PATRICK L | reporter.nih.gov |
| Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $1,805,996 | May 3, 2022 | April 30, 2025 | PERLSTEIN, ETHAN | reporter.nih.gov |
| Compromised LDH activity causes motor deficits and hastens ALS progression | NIH | National Institute on Aging | 2023 to 2025 | $1,805,312 | July 1, 1996 | January 31, 2028 | MILBRANDT, JEFFREY D | reporter.nih.gov |
| Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,799,500 | April 1, 2020 | January 31, 2026 | MCINTOSH, J MICHAEL | reporter.nih.gov |
| Translation Control of Pain Plasticity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,795,589 | March 15, 2010 | January 31, 2025 | PRICE, THEODORE J. | reporter.nih.gov |
| Mechanism of Enteric Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,794,310 | August 1, 2009 | July 31, 2028 | SRINIVASAN, SHANTHI K | reporter.nih.gov |
| Pre-clinical validation of 3D-printed nerve conduits for pediatric peripheral nerve repair | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,788,090 | June 27, 2023 | March 31, 2028 | CHEN, SHAOCHEN | reporter.nih.gov |
| Dance-based Avenues to Advance Nonpharmacologic treatment of Chemotherapy Effects (DAANCE): a multicenter trial | NIH | National Institute on Aging | 2024 to 2025 | $1,775,424 | September 20, 2024 | August 31, 2029 | WORTHEN-CHAUDHARI, LISE C. | reporter.nih.gov |
| The conserved mechanisms underlying different types of chronic pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,764,266 | August 15, 2022 | July 31, 2027 | LI, LINGYONG | reporter.nih.gov |
| Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity | NIH | National Cancer Institute | 2023 to 2025 | $1,751,883 | January 1, 2023 | December 31, 2027 | STAFF, NATHAN P | reporter.nih.gov |
| Dermatomal Mapping with Spinal Cord Functional Magnetic Resonance Imaging | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,744,537 | September 1, 2023 | May 31, 2028 | WEBER, KENNETH ARNOLD | reporter.nih.gov |
| Developing a new DFU dressing | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $1,741,462 | May 17, 2022 | January 31, 2025 | CHIEN, SUFAN | reporter.nih.gov |
| Development of a novel analgesic for mixed inflammatory and neuropathic pain states | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,734,409 | September 15, 2021 | August 31, 2023 | GHETTI, ANDREA | reporter.nih.gov |
| Non-Opioid Post-Operative Pain Management Using Bupivacaine-loaded Poly(ester urea) Mesh | NIH | National Institute of General Medical Sciences | 2021 | $1,730,751 | September 13, 2021 | August 31, 2023 | YU, JIAYI | reporter.nih.gov |
| Development of novel Amadorins for Diabetic Peripheral Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,723,731 | September 19, 2018 | July 31, 2024 | KHALIFAH, RAJA G | reporter.nih.gov |
| Prevention of paclitaxel-induced peripheral neuropathy with nilotinib | NIH | National Cancer Institute | 2021 to 2023 | $1,723,403 | April 17, 2019 | March 31, 2025 | HU, SHUIYING | reporter.nih.gov |
| Cannabidiol and terpenoid interactions in amygdalar regulation of pain states | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $1,717,472 | May 1, 2022 | January 31, 2027 | LAND, BENJAMIN | reporter.nih.gov |
| Schwann cell activation in oral cancer perineurial invasion and neuropathic pain | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,714,072 | April 1, 2020 | March 31, 2026 | YE, YI | reporter.nih.gov |
| Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial | NIH | National Cancer Institute | 2023 to 2025 | $1,709,232 | April 1, 2021 | September 30, 2026 | BAO, TING | reporter.nih.gov |
| Development and validation of an intraoperative imaging agent for the peripheral nervous system | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $1,698,454 | June 15, 2020 | February 28, 2024 | PILLARSETTY, NAGAVARAKISHORE | reporter.nih.gov |
| Neuro-immune mechanisms of minor cannabinoids in inflammatory and neuropathic pain | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $1,692,291 | September 15, 2019 | June 30, 2025 | HELLMAN, JUDITH | reporter.nih.gov |
| Transduction of Mechanical Stimuli in Myelination and Peripheral Nerve Repair | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,672,924 | January 15, 2020 | December 31, 2025 | POITELON, YANNICK | reporter.nih.gov |
| Home-Based Physical Activity Intervention for Taxane-Induced CIPN | NIH | National Cancer Institute | 2021 to 2023 | $1,668,669 | September 19, 2019 | December 31, 2024 | VISOVSKY, CONSTANCE G. | reporter.nih.gov |
| Development of an Integrated Risk Prediction Model of Taxane-induced Peripheral Neuropathy | NIH | National Cancer Institute | 2023 to 2025 | $1,662,683 | January 1, 2023 | December 31, 2027 | HERTZ, DANIEL LOUIS | reporter.nih.gov |
| Photoacoustic and epigenetic nerve scaffold for nerve regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,662,078 | May 18, 2022 | March 31, 2027 | YAN, SU | reporter.nih.gov |
| Folding, Misfolding, and Function of PMP22 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,650,616 | April 1, 2016 | January 31, 2028 | SANDERS, CHARLES R | reporter.nih.gov |
| Uncovering the roles of oxysterols in neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,648,312 | July 15, 2022 | May 31, 2028 | SALVEMINI, DANIELA | reporter.nih.gov |
| Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy | NIH | National Cancer Institute | 2022 to 2024 | $1,647,689 | September 1, 2020 | May 31, 2026 | JOHNSON, CONSTANCE MARGARET | reporter.nih.gov |
| Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy | NIH | National Cancer Institute | 2022 to 2025 | $1,647,046 | January 13, 2022 | December 31, 2026 | GEISLER, STEFANIE | reporter.nih.gov |
| JAX-Gladstone, SCGE Disease Models Studies Supplement | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,641,672 | September 25, 2018 | June 30, 2023 | CONKLIN, BRUCE R | reporter.nih.gov |
| Profiling Translation in Nociceptor Plasticity | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,634,786 | September 15, 2020 | May 31, 2030 | CAMPBELL, ZACHARY | reporter.nih.gov |
| Inhibiting RIPK1 with Necrostatin-1 for Safe and Effective Pain Treatment | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $1,633,790 | September 5, 2022 | August 31, 2025 | SHEN, SHIQIAN | reporter.nih.gov |
| Discovery and characterization of selective GIRK1/2 activators and their evaluation in preclinical models of pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,623,792 | April 1, 2022 | March 31, 2028 | HOPKINS, COREY R. | reporter.nih.gov |
| Diffusion MRI Biomarkers of Peripheral Nerve Trauma | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $1,622,655 | May 1, 2023 | April 30, 2025 | DORTCH, RICHARD | reporter.nih.gov |
| Stem Cell Surface Modification to Promote Nerve Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,617,912 | January 15, 2021 | December 31, 2026 | JIA, XIAOFENG | reporter.nih.gov |
| Safe Direct Current Stimulator (SDCS) technology for blocking chronicperipheral pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,611,872 | April 15, 2020 | March 31, 2025 | FRIDMAN, GENE YEVGENY | reporter.nih.gov |
| Regulation of SCI-induced pain by macrophages and exercise | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,610,456 | September 18, 2017 | June 30, 2028 | DETLOFF, MEGAN R | reporter.nih.gov |
| Investigating the contributions of voltage gated sodium channels to oxaliplatin induced neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $1,610,258 | September 21, 2022 | December 31, 2022 | YAROV-YAROVOY, VLADIMIR M | reporter.nih.gov |
| Sensory Phenotyping to Enhance Neuropathic Pain Drug Development | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,600,475 | September 21, 2023 | August 31, 2025 | FREEMAN, ROY | reporter.nih.gov |
| An innovative device for management of neuropathic pain after spinal cord injury | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,594,319 | September 19, 2024 | August 31, 2026 | LI, SHENG | reporter.nih.gov |
| Cortical Signature and Modulation of Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,587,995 | September 30, 2018 | February 29, 2024 | WANG, FAN | reporter.nih.gov |
| Development of CNS-Active 5-HT3R Antagonists for the Treatment of Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,587,553 | July 5, 2024 | June 30, 2026 | ELGENDY, BAHAA | reporter.nih.gov |
| Novel Circuits and Mechanisms of Descending Pain Modulation | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,579,926 | December 15, 2022 | November 30, 2027 | USACHEV, YURIY M | reporter.nih.gov |
| Endoplasmic Reticulum Stress Responses in Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,578,107 | February 15, 2020 | January 31, 2026 | ROMERO-SANDOVAL, E. ALFONSO | reporter.nih.gov |
| Impact of Schwann Cell Pathology on Axon Structure and Function | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,574,423 | December 1, 2022 | November 30, 2027 | SALZER, JAMES | reporter.nih.gov |
| Developing GPR37 activators as non-opioid pain therapeutics | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $1,573,491 | April 1, 2022 | March 31, 2025 | LA, JUN-HO | reporter.nih.gov |
| Cellular and Genetic Mechanisms of Autoimmune Diabetes Associated Neuritis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,572,053 | September 1, 2023 | June 30, 2028 | RACINE, JEREMY J | reporter.nih.gov |
| Developing equilibrative nucleoside transporter inhibitors as non-opioid pain therapeutics | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,563,778 | September 12, 2024 | August 31, 2026 | LEE, SEOK-YONG | reporter.nih.gov |
| Therapeutic and Mechanistic Evaluation of Cannabis sativa Terpenes in Neuropathic Pain | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $1,560,823 | July 1, 2021 | April 30, 2027 | STREICHER, JOHN MICHAEL | reporter.nih.gov |
| Topical Neurokinin-1 Receptor Antagonist as an Effective Non-addictive Analgesic for Ocular Pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,559,917 | August 5, 2024 | July 31, 2026 | DANA, REZA | reporter.nih.gov |
| Dissecting the Diverse Roles of Importin α at the Plasma Membrane | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,554,644 | August 1, 2022 | July 31, 2027 | BROWNLEE, CHRISTOPHER WILLIAM | reporter.nih.gov |
| Regenerative and degenerative responses to axonal injury | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,553,880 | April 1, 2010 | May 31, 2026 | COLLINS, CATHERINE A | reporter.nih.gov |
| Laminin Receptors and Signals in Schwann Cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,546,694 | July 1, 2003 | January 31, 2025 | SIM, FRASER JAMES | reporter.nih.gov |
| Novel mechanisms regulating protein interaction and pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,542,406 | December 15, 2019 | November 30, 2023 | DALVA, MATTHEW B | reporter.nih.gov |
| Extracellular mechanism regulating synaptic function and pain plasticity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,533,165 | September 1, 2019 | January 8, 2024 | DALVA, MATTHEW B | reporter.nih.gov |
| Sleep fragmentation by brief awakenings as a surrogate to measure neuropathic spontaneous pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,527,707 | April 1, 2020 | March 31, 2025 | LATREMOLIERE, ALBAN A | reporter.nih.gov |
| Cardiovascular and neuromuscular issues in chronic pain | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,525,114 | August 1, 2024 | May 31, 2028 | AMANN, MARKUS | reporter.nih.gov |
| Development of selective GPR34 antagonists for the treatment of neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,511,970 | September 19, 2024 | August 31, 2026 | SALVEMINI, DANIELA | reporter.nih.gov |
| Planning Study for the Development of Sigma 2 ligands as Analgesics | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,510,066 | September 11, 2023 | August 31, 2025 | TIDGEWELL, KEVIN JOSEPH | reporter.nih.gov |
| Pronociceptive and antinociceptive opioid mechanisms in the central nucleus of the amygdala | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,507,449 | August 15, 2019 | June 30, 2025 | NAVRATILOVA, EDITA | reporter.nih.gov |
| Role of TLR4-lipid rafts in nociception | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,503,288 | January 17, 2024 | December 31, 2028 | YAKSH, TONY L. | reporter.nih.gov |
| Choline-dependent metabolism in PNS myelination | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,502,243 | September 1, 2020 | May 31, 2026 | KIM, HAESUN A | reporter.nih.gov |
| Laboratory Developed Test (LDT) to Support Clinical Evaluation of a Drug for Painful Diabetic Neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,500,000 | September 20, 2021 | May 31, 2027 | RICHARDSON, THOMAS P | reporter.nih.gov |
| FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,500,000 | August 7, 2025 | July 31, 2027 | NESTI, EDMUND | reporter.nih.gov |
| Trans-BBB AAV9 gene therapy targeting CNS neuropathy of MPS I | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,499,504 | September 16, 2025 | August 31, 2027 | MCCARTY, DOUGLAS M | reporter.nih.gov |
| Enhancing Physical Therapy: Noninvasive Brain Stimulation System for Treating Carpal Tunnel Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $1,494,958 | September 21, 2022 | August 31, 2025 | WAGNER, TIMOTHY ANDREW | reporter.nih.gov |
| Development of Pathology-activated Drugs for Treatment of Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,485,925 | September 20, 2022 | August 31, 2027 | GRACE, PETER M | reporter.nih.gov |
| Establishing Oprm1 exon 7-associated variants as novel therapeutic targets for mitigating adverse effects of clinically used mu opioids without altering analgesia in pain management | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,483,529 | September 30, 2024 | May 31, 2029 | PAN, YING-XIAN | reporter.nih.gov |
| Schwann Cell Reprogramming after Nerve Injury | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,478,294 | June 1, 2023 | May 31, 2028 | SVAREN, JOHN P | reporter.nih.gov |
| Discovery of the Biomarker Signature for Neuropathic Corneal Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $1,470,840 | August 1, 2019 | July 31, 2025 | HAMRAH, PEDRAM | reporter.nih.gov |
| ACVR1 sensory neuron-specific signaling in neuropathic pain and injury-induced heterotopic ossification | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,470,746 | September 1, 2023 | June 30, 2028 | YU, XIAOBING | reporter.nih.gov |
| Myelin Autoantigens in Neuropathic Pain | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $1,467,994 | September 1, 2018 | August 31, 2024 | SHUBAYEV, VERONICA | reporter.nih.gov |
| A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy | NIH | National Cancer Institute | 2024 to 2025 | $1,464,067 | September 19, 2022 | August 31, 2027 | GELBER, COHAVA | reporter.nih.gov |
| Painful Versus Insensate Diabetic Neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,463,724 | January 1, 2003 | January 31, 2027 | WRIGHT, DOUGLAS E | reporter.nih.gov |
| Temporal effects of inflammation on the autonomic control of circulation during exercise in type 2 diabetic rats | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,453,944 | January 1, 2019 | December 31, 2024 | STONE, AUDREY J | reporter.nih.gov |
| Identifying mechanisms that regulate local axon vulnerability to pathological degeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,444,182 | April 1, 2022 | March 31, 2027 | SUMMERS, DANIEL | reporter.nih.gov |
| Functional Analysis of O-GlcNAc using Synthetic Protein Chemistry | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,442,331 | August 1, 2015 | July 31, 2025 | PRATT, MATTHEW ROBERT | reporter.nih.gov |
| Investigating the neutrophil-sensory neuron crosstalk in lung cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,435,793 | July 1, 2023 | June 30, 2028 | JIN, CHENGCHENG | reporter.nih.gov |
| Mechanistic Study of Pain Inhibition by Activation of Non-nociceptive Afferent Fibers | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,429,390 | March 1, 2019 | January 31, 2025 | GUAN, YUN | reporter.nih.gov |
| mRNA Splicing Modulation in Familial Dysautonomia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,426,656 | July 1, 2016 | June 30, 2024 | SLAUGENHAUPT, SUSAN A | reporter.nih.gov |
| Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity | NIH | National Cancer Institute | 2021 to 2023 | $1,422,549 | April 1, 2021 | August 31, 2023 | KROETZ, DEANNA L | reporter.nih.gov |
| Generalizing genome editing for rare disease-causing variants | NIH | Office of the Director, National Institutes of Health | 2025 | $1,416,375 | September 18, 2025 | August 31, 2028 | NEWBY, GREGORY A. | reporter.nih.gov |
| Spinal cord stimulation for the attenuation of chemotherapy-induced peripheral neuropathy and enhanced chemotherapeutic efficacy | NIH | National Cancer Institute | 2021 to 2025 | $1,412,130 | July 1, 2021 | June 30, 2026 | SIVANESAN, EELLAN | reporter.nih.gov |
| Identification of a Novel DRG-Specific Long Noncoding RNA and its Role in Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,410,785 | April 15, 2021 | March 31, 2027 | HU, HUIJUAN | reporter.nih.gov |
| RNA-Protein Interactions in Nociception | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,410,642 | April 1, 2022 | March 31, 2027 | HARRISON, BENJAMIN | reporter.nih.gov |
| Anti-CV2 autoantibodies unmask a CRMP5/GluN2B pain signaling hub | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,402,246 | May 14, 2022 | December 31, 2026 | MOUTAL, AUBIN | reporter.nih.gov |
| Discovery of Biomarker Signatures Prognostic for Neuropathic Pain after Acute Spinal Cord Injury | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,401,149 | September 1, 2019 | June 30, 2026 | HERGENROEDER, GEORGENE W | reporter.nih.gov |
| Brain Structural Biomarkers of Risk and Resilience to Pain Chronification | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,384,895 | December 1, 2022 | November 30, 2027 | GEHA, PAUL | reporter.nih.gov |
| Response-contingent learning to modulate synaptic plasticity for spinal cord injury | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $1,384,314 | September 1, 2025 | August 31, 2028 | SONG, SHANG | reporter.nih.gov |
| Novel SMARD1 Mouse Models: Characterization and Evaluation of Potential Therapeutic Targets | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,380,377 | February 1, 2020 | January 31, 2026 | LORSON, CHRISTIAN L. | reporter.nih.gov |
| Targeting of Alpha7 nAChR for therapeutic effects | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,377,281 | May 1, 2000 | June 30, 2024 | PAPKE, ROGER L | reporter.nih.gov |
| Biomarker development in patients with HNPP | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,376,111 | January 15, 2022 | December 31, 2025 | CHEN, YONGSHENG | reporter.nih.gov |
| The Role of the Complement System in Spinal Mechanisms of Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,375,806 | June 15, 2019 | May 31, 2025 | USACHEV, YURIY M | reporter.nih.gov |
| A Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain | NIH | National Institute of Nursing Research | 2021 to 2022 | $1,368,660 | August 27, 2018 | May 31, 2025 | ANASTASI, JOYCE K | reporter.nih.gov |
| Development of positive TMEM97 modulators for treating neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,352,240 | August 1, 2023 | July 31, 2025 | MARTIN, STEPHEN | reporter.nih.gov |
| Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy | NIH | National Cancer Institute | 2022 to 2025 | $1,351,202 | August 15, 2022 | July 31, 2027 | GOODE, DIANA J | reporter.nih.gov |
| Mechanisms of Epigenetic Plasticity in Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,344,471 | April 1, 2023 | March 31, 2028 | PAN, HUI-LIN | reporter.nih.gov |
| Targeting Endosomal Receptors for Treatment of Chronic Pain | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,337,416 | September 1, 2024 | August 31, 2025 | BUNNETT, NIGEL W | reporter.nih.gov |
| Therapeutic Electrical Stimulation Using Wireless, Resorbable Implants to Accelerate Diaphragm Muscle Reinnervation after Phrenic Neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,326,010 | May 15, 2024 | April 30, 2029 | FRANZ, COLIN | reporter.nih.gov |
| Investigating the Pathogenic Role of Tubulin Post-translational Modifications in CIPN | NIH | National Cancer Institute | 2024 to 2025 | $1,322,244 | September 1, 2024 | August 31, 2029 | BARTOLINI, FRANCESCA | reporter.nih.gov |
| The Role of ESCRTs in Regulating Nervous System Function | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,306,650 | December 1, 2019 | November 30, 2025 | WILSON, SCOTT MICHAEL | reporter.nih.gov |
| Understanding Neuronal Cell type-Specific Dysregulation in Familial Dysautonomia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,296,290 | July 1, 2016 | June 30, 2029 | SLAUGENHAUPT, SUSAN A | reporter.nih.gov |
| Translational control of stress response signaling | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,286,370 | September 22, 2023 | August 31, 2028 | RYOO, HYUNG D | reporter.nih.gov |
| Novel injectable analgesic delivery system for musculoskeletal pain management | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,280,693 | August 1, 2019 | June 30, 2025 | NAIR, LAKSHMI S | reporter.nih.gov |
| Cellular mechanisms of antidepressant drug actions in neuropathic pain models | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,272,357 | August 1, 2019 | July 1, 2022 | ZACHARIOU, VENETIA | reporter.nih.gov |
| Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial | NIH | National Cancer Institute | 2024 to 2025 | $1,263,296 | December 1, 2023 | November 30, 2025 | BAO, TING | reporter.nih.gov |
| Role of Primary Sensory Neuron CaMKII Signaling in Regulation of Pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,259,355 | May 1, 2024 | April 30, 2028 | PAN, BIN | reporter.nih.gov |
| α9α10 Nicotinic Acetylcholine Receptors in neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,248,720 | August 1, 2024 | June 30, 2029 | RILEY, ANDREW | reporter.nih.gov |
| Peripheral Nerve Regulation of Pancreas Cancer Progression | NIH | National Cancer Institute | 2024 to 2025 | $1,245,096 | July 1, 2024 | June 30, 2029 | SALOMAN, JAMI LYNN | reporter.nih.gov |
| Longitudinal assessment of the role of interoception in chemotherapy-induced peripheral neuropathy (CIPN) along the cancer chemotherapy continuum | NIH | National Cancer Institute | 2024 to 2025 | $1,244,265 | September 4, 2024 | August 31, 2029 | KLECKNER, IAN ROBERT | reporter.nih.gov |
| Neuron vasculature interactions in pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,243,506 | September 9, 2024 | August 31, 2029 | ZHANG, JUN-MING | reporter.nih.gov |
| Studies on RGS4-Regulated Pathways in Models of Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,241,005 | April 5, 2024 | March 31, 2029 | ZACHARIOU, VENETIA | reporter.nih.gov |
| Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,233,471 | September 15, 2020 | June 30, 2025 | WANG, LEI | reporter.nih.gov |
| The Effect of High Intensity Interval Training and Surgical Weight Loss On Distal Symmetric Polyneuropathy Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,223,000 | July 6, 2018 | February 28, 2025 | CALLAGHAN, BRIAN CHRISTOPHER | reporter.nih.gov |
| Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,221,295 | March 5, 2013 | January 31, 2023 | LEVINE, JON DAVID | reporter.nih.gov |
| Sarm1 and neural regulation of bone | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,220,859 | January 13, 2023 | November 30, 2026 | SCHELLER, ERICA LYNN | reporter.nih.gov |
| Brain Mechanisms of Chronic Low-Back Pain: Specificity and Effects of Aging and Sex | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,214,654 | April 1, 2023 | March 31, 2028 | GEHA, PAUL | reporter.nih.gov |
| Midbrain cholinergic modulation of pain states | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,207,359 | June 1, 2023 | May 31, 2028 | MCGEHEE, DANIEL S | reporter.nih.gov |
| Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity | NIH | National Cancer Institute | 2023 to 2025 | $1,201,082 | April 1, 2021 | March 31, 2027 | KROETZ, DEANNA L | reporter.nih.gov |
| Trans-synaptic signaling complex in amygdala pain mechanisms | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,198,149 | August 1, 2020 | December 31, 2023 | DRAVID, SHASHANK MANOHAR | reporter.nih.gov |
| Analgesic efficacy of single and combined minor cannabinoids and terpenes | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $1,188,750 | September 15, 2019 | June 30, 2025 | WARD, SARA J | reporter.nih.gov |
| Mitochondrial Regulation of Nociceptor Function | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,187,938 | February 15, 2023 | January 31, 2028 | MOLLIVER, DEREK C | reporter.nih.gov |
| NEURAXIAL AAVS TARGETING DRG CHANNELS INVOLVED IN CHRONIC POST INFLAMMATORY PAIN | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,182,994 | January 1, 2024 | December 31, 2028 | YAKSH, TONY L. | reporter.nih.gov |
| Understanding the role of patient-derived Ighmbp2 mutations in neurodegeneration and pre-rRNA processing | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,181,939 | January 1, 2024 | December 31, 2028 | LORSON, CHRISTIAN L. | reporter.nih.gov |
| Initial Development of AEG-1 inactivation as a possible strategy for pain treatment | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $1,179,675 | May 1, 2022 | April 30, 2024 | DAMAJ, M. IMAD | reporter.nih.gov |
| The role of neuroimmune interactions in the pathogenesis of chronic pain | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $1,172,064 | September 10, 2018 | December 31, 2024 | YANG, GUANG | reporter.nih.gov |
| Hierarchically-Structured Conduits with Programmed Release of Neurotrophic Factors for Repairing Large Defects in Thick Nerves | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,171,620 | May 15, 2023 | April 30, 2028 | XIA, YOUNAN | reporter.nih.gov |
| Spatiotemporal Coding in the Pain Circuit Along the Spine-brain Continuum | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,164,262 | September 15, 2018 | November 30, 2023 | SAAB, CARL Y | reporter.nih.gov |
| Metabolic control of gut-brain axis in Familial Dysautonomia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,161,056 | September 1, 2018 | May 31, 2025 | COPIE, VALERIE | reporter.nih.gov |
| A Novel Pathogenic Pathway for Diabetic Keratopathy | NIH | National Eye Institute | 2023 to 2025 | $1,148,250 | September 1, 2018 | December 31, 2027 | KARAMICHOS, DIMITRIOS | reporter.nih.gov |
| microRNA regulation of NMNAT-mediated Neuroprotection against Peripheral Neuropathy and Chronic Pain | NIH | National Center for Complementary & Integrative Health | 2022 to 2023 | $1,145,822 | August 16, 2019 | June 30, 2025 | ZHAI, RONG GRACE | reporter.nih.gov |
| Long-acting Injectable Protein Delivery System for Functional Repair of Peripheral Nerve Injury | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,143,739 | January 1, 2023 | November 30, 2028 | MAO, HAI-QUAN | reporter.nih.gov |
| Neuroimaging and Connectome Analysis as a Diagnostic and Prognostic Biomarker of SCI Induced Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,141,192 | December 26, 2023 | November 30, 2028 | ALIZADEH, MAHDI | reporter.nih.gov |
| A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,139,738 | September 1, 2021 | August 31, 2027 | ELFAR, JOHN | reporter.nih.gov |
| REST-mediated regulation of opioid receptors in chronic pain mouse models | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,135,224 | July 1, 2020 | June 30, 2027 | MAJUMDER, SADHAN | reporter.nih.gov |
| Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infection | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,132,485 | September 15, 2018 | May 31, 2025 | XU, KE | reporter.nih.gov |
| Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study | NIH | National Cancer Institute | 2021 to 2024 | $1,106,695 | January 10, 2019 | December 31, 2025 | SMITH, ELLEN MARY LAVOIE | reporter.nih.gov |
| Neural Mechanisms of Cancer Pain | NIH | National Cancer Institute | 2021 to 2023 | $1,105,536 | June 1, 2019 | May 31, 2025 | SIMONE, DONALD | reporter.nih.gov |
| Developing Chemical Probes for Inflammatory Pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,092,815 | August 1, 2022 | April 30, 2028 | ELGENDY, BAHAA | reporter.nih.gov |
| Single and Double AAV Somatic Gene Amelioration of Mouse Models of LAMA2 Related Dystrophy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,091,199 | August 7, 2025 | July 31, 2028 | YURCHENCO, PETER DANA | reporter.nih.gov |
| Tracking HIV Infection & Alcohol Abuse CNS Comorbidity with Neuroimaging | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $1,088,145 | September 30, 2007 | August 31, 2023 | PFEFFERBAUM, ADOLF | reporter.nih.gov |
| Neuroinflammation Grading and Adjusting of Spinal Sensorimotor Circuitries in Response to Remote Injuries in Peripheral Nerves | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,087,068 | April 1, 2020 | January 31, 2024 | ALVAREZ, FRANCISCO J | reporter.nih.gov |
| The role of SARM1 in neuroinflammation-mediated axonal damage | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,083,048 | April 10, 2024 | February 28, 2029 | MILBRANDT, JEFFREY D | reporter.nih.gov |
| Investigating the role of gut extracellular vesicles in diabetic peripheral neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,082,069 | March 1, 2024 | January 31, 2028 | LIU, XIANSHUANG | reporter.nih.gov |
| Modulation of CSF1R Signaling to Treat Inflammatory Neuropathies | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,081,356 | December 15, 2023 | November 30, 2028 | SHEIKH, KAZIM A | reporter.nih.gov |
| Comprehensive gene and DNA variant curation for neuromuscular diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,079,672 | June 15, 2021 | May 31, 2025 | ZUCHNER, STEPHAN | reporter.nih.gov |
| Neuroimmune mechanisms of a humanized CCK-B receptor scFv as therapy for chronic pain patients | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,076,942 | June 1, 2022 | August 31, 2023 | WESTLUND-HIGH, KARIN N. | reporter.nih.gov |
| HIV Tat-associated Sensory Neuropathy and the Contribution of Toll-like Receptor Pathway | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,065,000 | September 19, 2023 | August 31, 2028 | CAO, LING | reporter.nih.gov |
| Enduring enhancement of neuropathic pain by early post-trauma morphine | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,060,844 | July 1, 2018 | April 30, 2025 | WATKINS, LINDA | reporter.nih.gov |
| Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy | NIH | National Cancer Institute | 2023 to 2025 | $1,054,425 | June 9, 2023 | May 31, 2028 | BUCZYNSKI, MATTHEW WALLACE | reporter.nih.gov |
| Metabolic regulation of KLHL proteins through O-glycosylation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,053,916 | June 15, 2019 | March 31, 2024 | CHI, JEN-TSAN ASHLEY | reporter.nih.gov |
| Angiotensin Signaling Underlies Myeloid and Sensory Disruption in Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,049,838 | May 2, 2024 | April 30, 2028 | SHEPHERD, ANDREW JOHN | reporter.nih.gov |
| Molecular mechanisms of somatosensory adaptation to prolonged hypothermia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,047,112 | December 21, 2023 | November 30, 2028 | BAGRIANTSEV, SVIATOSLAV | reporter.nih.gov |
| 15-LOX-1 as a druggable target in the acute to chronic pain transition of rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,041,920 | July 1, 2019 | May 31, 2025 | GREGUS, ANN MARIE | reporter.nih.gov |
| Endocannabinoid Biosynthesis in Inflammation and Pain | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,034,700 | February 1, 2024 | January 31, 2029 | HSU, KU-LUNG | reporter.nih.gov |
| Anti-inflammatory Effects of Novel Minor Cannabinoids and Terpenes on Cellular and Murine Models of HIV and HIV Proteins | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,034,538 | September 30, 2020 | July 31, 2025 | PARIS, JASON RICHARD | reporter.nih.gov |
| Dorsal horn circuits for mechanical allodynia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,032,136 | June 15, 2019 | March 31, 2024 | SEAL, REBECCA P | reporter.nih.gov |
| Mechanisms of Central Sensitization | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,028,014 | April 1, 2018 | March 31, 2025 | GEREAU, ROBERT W | reporter.nih.gov |
| Technology development for closed-loop deep brain stimulation to treat refractory neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,022,290 | July 1, 2019 | June 30, 2024 | CHANG, EDWARD | reporter.nih.gov |
| Role of dorsal root ganglion FTO, a RNA demethylase, in neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $1,019,768 | July 15, 2019 | April 30, 2025 | TAO, YUAN-XIANG | reporter.nih.gov |
| Role of a Fatty Acid Chaperone in Schwann Cell Myelination | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,019,124 | February 1, 2024 | January 31, 2029 | BELIN, SOPHIE | reporter.nih.gov |
| A role for the p75 neurotrophin receptor in Schwann cell regulation of sensory neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,018,116 | July 1, 2018 | May 31, 2024 | CARTER, BRUCE D | reporter.nih.gov |
| Investigation of neural ensembles driving pain chronification | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,017,362 | December 15, 2022 | November 30, 2027 | BEIER, KEVIN T | reporter.nih.gov |
| MECHANISMS OF TRPV4-MEDIATED NEUROPATHIC PAIN | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $1,010,646 | September 15, 2018 | June 30, 2023 | HU, HONGZHEN | reporter.nih.gov |
| Thermal Imaging Modality for Detection of Large and Small Fiber Diabetic Peripheral Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $1,001,136 | September 22, 2022 | August 31, 2024 | SOLIZ, PETER N | reporter.nih.gov |
| Endogenous opioid regulation of locus coeruleus-mediated analgesia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $996,499 | July 1, 2024 | June 30, 2029 | MCCALL, JORDAN G. | reporter.nih.gov |
| Primary afferent plasticity in chronic pain | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $994,822 | September 1, 2018 | June 30, 2024 | CHUNG, MAN-KYO | reporter.nih.gov |
| Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $985,495 | September 30, 2014 | April 30, 2023 | HANSEN, ANGELA | reporter.nih.gov |
| Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2024 | $982,702 | September 25, 2023 | August 31, 2025 | XIE, XINMIN SIMON | reporter.nih.gov |
| Identification of a novel DRG-specific long noncoding RNA and its role in neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $981,820 | April 15, 2021 | March 31, 2023 | HU, HUIJUAN | reporter.nih.gov |
| Emerging Neuroviruses and Neurological Inflammatory Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $974,046 | July 15, 2019 | April 30, 2025 | PARDO-VILLAMIZAR, CARLOS A | reporter.nih.gov |
| TNF in Injury and Repair Processes Following Traumatic SCI | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $962,884 | April 1, 2005 | April 30, 2029 | BETHEA, JOHN ROLAND | reporter.nih.gov |
| An exercise intervention to Reduce Neuropathic Pain and Brain Inflammation after Spinal Cord Injury | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $957,523 | September 1, 2019 | August 31, 2024 | LINNMAN, CLAS | reporter.nih.gov |
| microRNA regulation of NMNAT-mediated Neuroprotection against Peripheral Neuropathy and Chronic Pain | NIH | National Center for Complementary & Integrative Health | 2024 | $949,953 | July 10, 2024 | June 30, 2025 | ZHAI, RONG GRACE | reporter.nih.gov |
| Complement in Paclitaxel-induced peripheral neuropathy | NIH | National Cancer Institute | 2021 to 2024 | $936,532 | March 5, 2020 | February 28, 2026 | XU, JIJUN | reporter.nih.gov |
| Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy | NIH | National Institute on Drug Abuse | 2021 to 2022 | $929,035 | July 15, 2018 | May 31, 2024 | ROY, SABITA | reporter.nih.gov |
| Molecular Mechanism of Brain Regulation of Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $928,980 | February 1, 2020 | July 31, 2025 | ZHU, MICHAEL X | reporter.nih.gov |
| Determine Functions of Mammalian Touch-sensing Neurons in Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $923,704 | July 1, 2013 | June 30, 2023 | LUO, WENQIN | reporter.nih.gov |
| Sympathetic Function in Neural Injuries | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $923,372 | September 23, 2021 | November 30, 2026 | WARD, PATRICIA JILL | reporter.nih.gov |
| Trans-synaptic signaling complex in amygdala pain mechanisms | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $920,784 | August 1, 2020 | July 31, 2026 | DRAVID, SHASHANK MANOHAR | reporter.nih.gov |
| Tacrolimus-eluting nerve guidance conduit for enhanced regeneration in critical-sized peripheral nerve injuries | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $919,846 | September 30, 2019 | April 30, 2027 | AZAPAGIC, AZUR | reporter.nih.gov |
| Adenylyl cyclase signaling in persistent pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $919,730 | August 1, 2019 | April 30, 2025 | MOLLIVER, DEREK C | reporter.nih.gov |
| (PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN) | NIH | National Cancer Institute | 2021 to 2022 | $912,411 | September 10, 2018 | August 31, 2023 | FEHRENBACHER, JILL C | reporter.nih.gov |
| Non-invasive Electrical Stimulation as a Therapy for Diabetic Keratopathy | NIH | National Eye Institute | 2025 | $896,046 | September 1, 2025 | August 31, 2027 | YANG, MENGLU | reporter.nih.gov |
| Sexual dimorphism of neuroimmune interactions in temporomandibular joint disorders pain: contribution of a newly identified female-specific pain signaling axis IL23/IL17A/TRPV1 | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $888,913 | September 1, 2018 | June 30, 2024 | CHEN, YONG | reporter.nih.gov |
| Develop pan-specific antibody against mutant glycyl-tRNA synthetase for treating CMT2D | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $887,500 | January 1, 2021 | March 31, 2024 | YANG, XIANG-LEI | reporter.nih.gov |
| Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $873,042 | June 8, 2023 | June 30, 2027 | ZHAO, RUIMING | reporter.nih.gov |
| A Female Specific Role of RGSz1 in Modulation of Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $871,461 | July 1, 2020 | January 31, 2023 | ZACHARIOU, VENETIA | reporter.nih.gov |
| A Novel Role for Nav1.1 in Mammalian Thermosensation | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $871,280 | August 1, 2022 | July 31, 2027 | GRIFFITH, THEANNE NICOLE | reporter.nih.gov |
| Role of immune cells in skin reinnervation by collateral sprouting after peripheral nerve injury | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $870,578 | April 1, 2024 | March 31, 2029 | JEON, SANGMIN | reporter.nih.gov |
| Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $869,391 | April 1, 2022 | March 31, 2024 | AL-HASANI, REAM | reporter.nih.gov |
| The role of cell-specific TLR-4 signaling in oxaliplatin-induced peripheral neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $864,952 | September 15, 2018 | June 30, 2025 | WHITE, FLETCHER A | reporter.nih.gov |
| 5-HT3 receptor antagonists for neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $853,082 | February 15, 2018 | January 31, 2024 | HAROUTOUNIAN, SIMON | reporter.nih.gov |
| Developing multi-cue piezoelectric PVDF-TrFE biomaterials for peripheral nerve repair | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $851,956 | January 1, 2024 | December 31, 2028 | HARRIS, GREG M | reporter.nih.gov |
| tRNA Gene Replacement Therapy for tRNA-Synthetase Related Charcot-Marie-Tooth Disorder | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $841,280 | July 1, 2024 | March 31, 2027 | BURGESS, ROBERT W. | reporter.nih.gov |
| Development of Angiotensin AT2 inhibitors for neuropathic pain relief | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $818,360 | June 1, 2025 | May 31, 2029 | KATRITCH, VSEVOLOD | reporter.nih.gov |
| Thoracic Neuromodulation for Diabetic Gastroparesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $813,671 | July 15, 2022 | May 31, 2025 | SHARMA, AMOL | reporter.nih.gov |
| Role of Complex Sphingolipids in Diabetic Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $808,306 | August 15, 2020 | May 31, 2026 | FRIDMAN, VERA | reporter.nih.gov |
| The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy | NIH | National Cancer Institute | 2024 to 2025 | $805,748 | September 1, 2024 | August 31, 2029 | YANG, QING | reporter.nih.gov |
| Pathogenesis in Segmental Demyelination | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $804,961 | June 1, 2023 | May 31, 2028 | HU, BO | reporter.nih.gov |
| Primary sensory neuron-targeted block of Cav3.2 for treatment of chronic neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $799,591 | August 1, 2021 | July 31, 2024 | YU, HONGWEI | reporter.nih.gov |
| Optimization of Non Invasive Brain Stimulation for Diabetic Neuropathic Pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $793,388 | December 10, 2020 | May 31, 2024 | WAGNER, TIMOTHY ANDREW | reporter.nih.gov |
| In-depth characterization of B-cell dysfunction in chronic inflammatory demyelinating polyneuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $792,143 | April 1, 2024 | March 31, 2029 | ROY, BHASKAR | reporter.nih.gov |
| REST-mediated epigenomic and transcriptomic signatures in neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $791,971 | September 15, 2019 | July 31, 2024 | MAJUMDER, SADHAN | reporter.nih.gov |
| Store-operated channels in the nervous system | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $790,169 | February 13, 2007 | June 30, 2024 | PRAKRIYA, MURALI | reporter.nih.gov |
| Complex Autonomic Neuropathic Dysfunction Leading to Gastrointestinal and Immune Effects in People with HIV (CANDLE) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $789,126 | September 1, 2025 | June 30, 2030 | ROBINSON-PAPP, JESSICA | reporter.nih.gov |
| Developing Chemical Probes for Inflammatory Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $784,934 | August 1, 2022 | September 30, 2023 | ELGENDY, BAHAA | reporter.nih.gov |
| Chronic Pain Diagnosis and Treatment in Torture Survivors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $779,760 | September 15, 2020 | August 31, 2025 | KAUR, GUNISHA | reporter.nih.gov |
| Neuropathic Pain-induced Depression: the Role of mPFC Endocannabinoids | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $779,283 | August 15, 2019 | January 31, 2024 | PAN, BIN | reporter.nih.gov |
| Development and Validation of a Clinically Relevant Animal Pain Model | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $777,168 | July 1, 2020 | June 30, 2024 | SHEN, SHIQIAN | reporter.nih.gov |
| The impact of medical cannabis on pain and inflammation in people living with HIV | NIH | National Institute on Drug Abuse | 2021 to 2024 | $776,700 | July 15, 2021 | February 28, 2026 | SLAWEK, DEEPIKA | reporter.nih.gov |
| Examining the roles A-delta LTMRs and BDNF signaling play in neuropathic pain after SCI | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $773,164 | July 1, 2018 | June 30, 2024 | GARRAWAY, SANDRA M. | reporter.nih.gov |
| Dronabinol for the reduction of chronic pain and inflammation in people with sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $773,104 | June 1, 2022 | May 31, 2027 | CURTIS, SUSANNA | reporter.nih.gov |
| Myelin Junction Therapy in Peripheral Neuropathies | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $769,539 | March 15, 2020 | December 31, 2025 | LI, JUN | reporter.nih.gov |
| Small Molecule Tools for Modulating Membrane Rafts | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $764,342 | September 1, 2020 | August 31, 2024 | KENWORTHY, ANNE K | reporter.nih.gov |
| Community Health and Neuropathy: Nutritional and Environmental Links in Zambia (CHANNELZ) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $756,277 | August 5, 2021 | July 31, 2025 | KVALSUND, MICHELLE POWELL | reporter.nih.gov |
| Biomechanical treatment of carpal tunnel syndrome for Hispanic women | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $755,220 | August 1, 2024 | July 31, 2025 | LI, ZONG-MING | reporter.nih.gov |
| Molecular Dissection of the Axonal Injury Response for Regeneration and Neuroprotection | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $752,000 | April 1, 2020 | March 31, 2023 | WATKINS, TRENT | reporter.nih.gov |
| A Novel Pharmacologic Approach to Treat CMT1X | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $751,688 | September 15, 2020 | August 31, 2024 | DOBROWSKY, RICK T | reporter.nih.gov |
| Molecular Dissection of the Axonal Injury Response for Regeneration and Neuroprotection | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $747,663 | April 1, 2023 | March 31, 2026 | WATKINS, TRENT | reporter.nih.gov |
| Sphingolipid and Fatty Acid Biology in Prediabetes and Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $747,000 | September 15, 2021 | May 31, 2024 | RUMORA, AMY E. | reporter.nih.gov |
| The Role of Tau Phosphorylation in Diabetic Peripheral Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $747,000 | September 1, 2025 | August 31, 2028 | NICHOLS, JAMES M | reporter.nih.gov |
| Fn14, non-canonical NF-kappaB and downstream signaling in neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $746,244 | September 1, 2018 | May 31, 2024 | SIMARD, J. MARC | reporter.nih.gov |
| Pain in Hidradenitis Suppurativa: Phenotypes and Stakeholder Perspectives | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $743,903 | July 8, 2022 | June 30, 2027 | ORENSTEIN, LAUREN ANNE VIGIL | reporter.nih.gov |
| Nuclear lipid-sensor in Type II Diabetic Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $742,138 | March 1, 2018 | May 31, 2023 | MANSUY AUBERT, VIRGINIE | reporter.nih.gov |
| Human Disease Modeling of Glaucomatous Neuropathy | NIH | National Eye Institute | 2021 to 2022 | $739,625 | March 1, 2019 | February 28, 2025 | AHMAD, IQBAL | reporter.nih.gov |
| Myelin Junction Therapy in Peripheral Neuropathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $735,456 | March 15, 2020 | July 11, 2022 | LI, JUN | reporter.nih.gov |
| Development of a Splicing Modulator Compound for Familial Dysautonomia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $735,428 | May 1, 2023 | May 31, 2027 | SLAUGENHAUPT, SUSAN A | reporter.nih.gov |
| Integrative Medicine for Pain Management in Sickle Cell Disease | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $734,872 | July 17, 2018 | August 31, 2025 | WANG, YING | reporter.nih.gov |
| Abnormal Gene Splicing in Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $734,116 | July 1, 2020 | December 31, 2025 | LOPEZ SOTO, EDUARDO JAVIER | reporter.nih.gov |
| PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain | NIH | National Cancer Institute | 2021 to 2023 | $726,198 | May 22, 2018 | April 30, 2025 | GRACE, PETER M | reporter.nih.gov |
| Vagal and spinal afferent mapping of rat and human hearts in health and disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $726,035 | September 12, 2025 | June 30, 2030 | CHENG, ZIXI JACK | reporter.nih.gov |
| Molecular and cellular mechanisms of cold allodynia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $721,876 | July 1, 2018 | September 11, 2024 | MCKEMY, DAVID D | reporter.nih.gov |
| Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $720,183 | April 1, 2022 | March 31, 2027 | AL-HASANI, REAM | reporter.nih.gov |
| Biomechanics and strength in the distal upper limb influence median nerve health in manual wheelchair users | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $719,222 | August 11, 2025 | April 30, 2030 | MURRAY, WENDY M | reporter.nih.gov |
| Risk Factors and Outcomes Associated with Late-Life Diabetic Peripheral Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $712,576 | April 1, 2020 | April 30, 2025 | HICKS, CAITLIN WHITNEY | reporter.nih.gov |
| Exosomes and platinum-induced peripheral neuropathy | NIH | National Cancer Institute | 2021 to 2022 | $709,918 | July 1, 2018 | June 30, 2024 | ZHANG, ZHENG GANG | reporter.nih.gov |
| The Flint Neuropathy Study: assessing diagnostic and management gaps in a Black, low-income population-supplement | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $708,801 | January 1, 2025 | June 30, 2028 | ELAFROS, MELISSA | reporter.nih.gov |
| Estradiol and Zoster Associated Orofacial Pain | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $706,716 | April 1, 2018 | March 31, 2025 | KRAMER, PHILLIP R | reporter.nih.gov |
| Targeting GPCRs in amygdalar and cortical neural ensembles to treat pain aversion | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $705,382 | September 15, 2020 | June 30, 2025 | SCHERRER, GREGORY | reporter.nih.gov |
| Structural Biology of Connexin Membrane Channels | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $705,371 | July 1, 2020 | June 30, 2025 | YEAGER, MARK JAY | reporter.nih.gov |
| Chemokine-receptor profiling for painful diabetic neuropathy in biological samples from human clinical trials | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $700,128 | September 20, 2021 | December 15, 2023 | RICHARDSON, THOMAS P | reporter.nih.gov |
| Optimization of an HCN1-Selective Inverse Agonist for the Treatment of Peripheral Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $698,818 | September 23, 2022 | August 31, 2025 | FOX, STEVEN R | reporter.nih.gov |
| Targeting TLR4-lipid rafts to prevent postoperative pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $698,036 | September 21, 2023 | August 31, 2025 | DOUGHERTY, PATRICK M | reporter.nih.gov |
| Structural Biology of Connexin Membrane Channels | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $693,855 | July 1, 2020 | October 31, 2022 | YEAGER, MARK JAY | reporter.nih.gov |
| Opioid-Sparing Non-Surgical, Bioresorbable Nerve Stimulator for Pain Relief | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $693,472 | September 20, 2023 | August 31, 2025 | CUI, XINYAN TRACY | reporter.nih.gov |
| Hippo Regulation of Peripheral Myelination and Nerve Repair | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $693,438 | June 1, 2018 | March 31, 2025 | SON, YOUNG-JIN | reporter.nih.gov |
| Cellular and Molecular Role of CXCR4 signaling in Painful Diabetic Neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $691,250 | December 1, 2017 | November 30, 2022 | MENICHELLA, DANIELA M | reporter.nih.gov |
| Green Light Therapy for Chronic Pain | NIH | National Center for Complementary & Integrative Health | 2021 to 2022 | $690,750 | July 16, 2018 | May 31, 2023 | IBRAHIM, MOHAB M | reporter.nih.gov |
| A new pathway of spinal neurons in neuropathic pain induced by HIV with opioid | NIH | National Institute on Drug Abuse | 2021 to 2022 | $690,750 | September 30, 2018 | July 31, 2024 | HAO, SHUANGLIN | reporter.nih.gov |
| The Molecular Mechanism and Therapeutics in Axon Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $682,500 | September 30, 2018 | December 31, 2023 | ENGLISH, ARTHUR W. | reporter.nih.gov |
| Central and Peripheral Measures of Pain: Recovery and Resistance | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $676,623 | July 1, 2015 | November 30, 2022 | KOHANE, DANIEL S | reporter.nih.gov |
| The role of the glial engulfment receptor Jedi1 in regulating sensory neuron function | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $676,059 | April 1, 2018 | March 31, 2024 | CARTER, BRUCE D | reporter.nih.gov |
| Validation of Fibroblast-Derived PI16 as a Novel Target for pain Treatment | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $675,862 | September 30, 2020 | August 31, 2025 | SHEPHERD, ANDREW JOHN | reporter.nih.gov |
| Development of non-opioid, non-addictive analgesics for treating neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $675,107 | March 18, 2025 | January 31, 2030 | THAKUR, GANESH A | reporter.nih.gov |
| Developing evidence-based objective tools for managing children with auditory neuropathy spectrum disorder | NIH | National Institute on Deafness and Other Communication Disorders | 2025 | $670,525 | May 1, 2025 | April 30, 2030 | HE, SHUMAN | reporter.nih.gov |
| Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy | NIH | National Cancer Institute | 2021 | $669,413 | September 1, 2020 | October 31, 2021 | YEH, CHAO HSING | reporter.nih.gov |
| Mesolimbic adaptations underlying altered reward sensitivity in neuropathic pain | NIH | National Institute on Drug Abuse | 2025 | $668,131 | August 15, 2025 | April 30, 2030 | CREED, MEAGHAN C | reporter.nih.gov |
| Dissection of NTSR2/calcium channel signaling as a non-opioid spinal analgesic mechanism for the treatment of high impact chronic pain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $664,772 | February 1, 2025 | November 30, 2029 | PATWARDHAN, AMOL M | reporter.nih.gov |
| HAPPINESS: cHAnging the Perceived Pain INtensity in populations with Spinal cord injury and with health disparities | NIH | National Center for Complementary & Integrative Health | 2024 | $664,224 | February 23, 2024 | January 31, 2027 | VAN DE WINCKEL, ANN L | reporter.nih.gov |
| Selective Probes for Alpha9* Nicotinic Acetylcholine Receptors | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $650,079 | March 1, 2025 | February 28, 2030 | THAKUR, GANESH A | reporter.nih.gov |
| Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $639,395 | September 24, 2019 | June 30, 2024 | LUO, ZHIGANG DAVID | reporter.nih.gov |
| Molecular mechanisms underlying mitochondria-lysosome membrane contact sites in neuronal function and neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $633,556 | September 30, 2018 | November 30, 2023 | WONG, YVETTE | reporter.nih.gov |
| A Female Specific Role of RGSz1 in Modulation of Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $633,045 | July 1, 2020 | June 30, 2025 | ZACHARIOU, VENETIA | reporter.nih.gov |
| Role of Primary Sensory Neuron CaMKII Signaling in Regulation of Pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $621,180 | June 1, 2023 | January 31, 2024 | PAN, BIN | reporter.nih.gov |
| Nociplastic mechanisms in temporomandibular disorders: Separating nociception from pain | NIH | National Institute of Dental & Craniofacial Research | 2024 | $610,399 | August 1, 2024 | July 31, 2026 | HARPER, DANIEL ELLIOTT | reporter.nih.gov |
| Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy | NIH | National Cancer Institute | 2021 to 2022 | $604,292 | September 13, 2018 | July 31, 2024 | COPE, TIMOTHY C | reporter.nih.gov |
| Midcareer K24 Award for Mentoring and Patient-Oriented Research | NIH | National Institute on Drug Abuse | 2023 to 2025 | $602,500 | February 1, 2023 | January 31, 2028 | COFFIN, PHILLIP O | reporter.nih.gov |
| Damage-associated molecular patterns in chemotherapy toxicity | NIH | National Cancer Institute | 2025 | $601,091 | April 1, 2025 | March 31, 2030 | EISENMANN, ERIC DANIEL | reporter.nih.gov |
| Investigation of Mechanical Allodynia Circuitry by the Nature of the Injury | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $597,999 | March 15, 2025 | January 31, 2030 | SEAL, REBECCA P | reporter.nih.gov |
| Senescent stromal cells drive chemotherapy-induced peripheral neuropathy | NIH | National Institute on Aging | 2025 | $589,106 | June 1, 2025 | March 31, 2030 | STEWART, SHEILA A | reporter.nih.gov |
| Probing the role of serotonin in neuropathic pain with flexible carbon microelectrode arrays | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $583,463 | June 1, 2022 | March 31, 2028 | CASTAGNOLA, ELISA | reporter.nih.gov |
| The role of cell-specific TLR4 in Diabetic Peripheral Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $577,200 | July 8, 2022 | May 31, 2025 | BURTON, MICHAEL D | reporter.nih.gov |
| Mapping Neural Recovery: Visualizing Peripheral Nerve Regeneration and Brain Plasticity Post-Peripheral Nerve Injury | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $567,037 | August 1, 2025 | July 31, 2030 | BEREZIN, MIKHAIL Y. | reporter.nih.gov |
| Neural Coding and Control of Pain Detection in Somatosensory Cortex | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $560,934 | April 1, 2025 | March 31, 2030 | SAAB, CARL Y | reporter.nih.gov |
| Novel Interventions for Chemotherapy-Induced Neuropathy | NIH | National Institute on Aging | 2021 to 2022 | $553,341 | August 15, 2021 | December 31, 2023 | WORTHEN-CHAUDHARI, LISE C. | reporter.nih.gov |
| Regenerative and degenerative responses to axonal injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $546,913 | April 1, 2010 | May 31, 2022 | COLLINS, CATHERINE A | reporter.nih.gov |
| Development of selective calpain-1 inhibitors for chronic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $546,376 | July 1, 2021 | December 31, 2023 | NWANKWO, JENNIFER O | reporter.nih.gov |
| Spatial considerations in neuronal survival signals | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $545,358 | August 15, 2005 | April 30, 2023 | SEGAL, ROSALIND A. | reporter.nih.gov |
| Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy | NIH | National Institute of Nursing Research | 2021 | $542,043 | March 21, 2012 | June 30, 2024 | DORSEY, SUSAN G | reporter.nih.gov |
| Role of 3D chromatin architecture in axonal regeneration following peripheral nerve injury | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $540,322 | August 1, 2025 | July 31, 2027 | PALMISANO, ILARIA | reporter.nih.gov |
| Mechanisms of neuroprotection in diabetic peripheral neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $539,360 | April 1, 2021 | March 31, 2022 | HOKE, AHMET | reporter.nih.gov |
| (PQ9)Mechanistic Role of APE1 and BER in chemotherapy-induced peripheral neuropathy | NIH | National Cancer Institute | 2021 | $537,592 | April 1, 2017 | March 31, 2023 | KELLEY, MARK R. | reporter.nih.gov |
| Visualizing trigeminal neuralgia at 7 Tesla: Advancing etiological understanding and improving future clinical imaging protocols | NIH | National Institute of Dental & Craniofacial Research | 2022 | $532,102 | September 6, 2022 | May 31, 2025 | BALCHANDANI, PRITI | reporter.nih.gov |
| Immune Metabolism of Peripheral Nervous Tissue Degeneration and Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $531,478 | August 1, 2025 | July 31, 2030 | GIGER, ROMAN JENO | reporter.nih.gov |
| Profiling Translation in Nociceptor Plasticity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $530,647 | September 15, 2020 | July 14, 2022 | CAMPBELL, ZACHARY | reporter.nih.gov |
| Development of a novel survey to screen for chemotherapy-induced peripheral neuropathy in young children | NIH | National Cancer Institute | 2024 to 2025 | $511,478 | September 1, 2024 | August 31, 2029 | RODWIN, ROZALYN | reporter.nih.gov |
| Role of dorsal root ganglion FTO, a RNA demethylase, in neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $509,884 | July 15, 2019 | April 30, 2022 | TAO, YUAN-XIANG | reporter.nih.gov |
| Compromised LDH activity causes motor deficits and hastens ALS progression | NIH | National Institute on Aging | 2022 | $503,248 | July 1, 1996 | April 30, 2023 | MILBRANDT, JEFFREY D | reporter.nih.gov |
| Closed-Loop Micromagnetic Neuromodulation as a Non-Opioid Treatment for Neuropathic Pain. | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $500,000 | September 1, 2021 | August 31, 2023 | REILLY, THOMAS | reporter.nih.gov |
| PNM-CAP: A novel nerve cap to prevent painful neuroma formation in peripheral nerve injuries and amputations | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $500,000 | September 1, 2025 | August 31, 2026 | SOLETTI, LORENZO | reporter.nih.gov |
| Restoration of Neuromuscular Function Following Critical Nerve Gap Injuries | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $499,999 | September 19, 2024 | August 31, 2025 | SOLETTI, LORENZO | reporter.nih.gov |
| Uncovering astrocyte contributions to neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $499,979 | April 15, 2025 | March 31, 2030 | NIMMERJAHN, AXEL | reporter.nih.gov |
| Parmodulins without Abuse Potential for the Treatment of Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $499,863 | September 11, 2025 | August 31, 2027 | DOCKENDORFF, CHRISTOPHER | reporter.nih.gov |
| Mechanisms of Regeneration: Facial Nerve Injury and Repair | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $499,608 | September 9, 2019 | August 31, 2024 | PEPPER, JON-PAUL | reporter.nih.gov |
| Charcot-Marie-Tooth Disease Type 2E: Mechanism and therapy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $499,452 | May 15, 2025 | April 30, 2030 | BROWN, ANTHONY | reporter.nih.gov |
| Post-translational regulation of opioid and cannabinoid receptors | NIH | National Institute on Drug Abuse | 2021 | $498,194 | April 1, 2017 | March 31, 2023 | DEVI, LAKSHMI A | reporter.nih.gov |
| Autoimmune Mechanisms in Peripheral Neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $496,747 | September 30, 2018 | August 31, 2023 | SU, MAUREEN A | reporter.nih.gov |
| Restoration of Muscular Function Following Direct Muscle Neurotization | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $494,955 | September 15, 2023 | August 31, 2025 | SOLETTI, LORENZO | reporter.nih.gov |
| Role of a conserved miRNA regulatory axis in neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $492,439 | July 1, 2018 | April 30, 2023 | CATERINA, MICHAEL J | reporter.nih.gov |
| Neuronal and glial interactions of neuropathic pain | NIH | National Institute of Dental & Craniofacial Research | 2021 | $488,534 | July 1, 2006 | March 31, 2023 | BUCHHEIT, THOMAS | reporter.nih.gov |
| Antagonists of CRMP2 Phosphorylation for Chemotherapy-Induced Peripheral Neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $486,793 | September 15, 2022 | December 31, 2023 | KHANNA, RAJESH | reporter.nih.gov |
| Function and Regulation of PMP22 in CMT1A and HNPP | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $481,950 | September 21, 2021 | March 31, 2024 | MOSS, KATHRYN RENAE | reporter.nih.gov |
| Dissecting the Integrated Stress Response in tRNA Synthetase-Associated Neuropathies | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $481,875 | March 1, 2023 | February 28, 2025 | BURGESS, ROBERT W. | reporter.nih.gov |
| Evaluating the Blood-Brain Barrier Bioavailability and in vivo Efficacy Potential of a Novel TAK1 Inhibitor Targeting Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $480,955 | September 8, 2021 | August 31, 2023 | SCARNEO, SCOTT | reporter.nih.gov |
| Regenerative Strategies Targeting Retinoic Acid Signaling in Giant Axonal Neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $479,397 | May 14, 2025 | April 30, 2030 | SNIDER, NATASHA T | reporter.nih.gov |
| Function and Regulation of PMP22 in CMT1A and HNPP | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $469,902 | September 21, 2021 | March 31, 2027 | MOSS, KATHRYN RENAE | reporter.nih.gov |
| Discovery of novel openers of the understudied human drug target Kir6.1 | NIH | National Center for Advancing Translational Sciences | 2022 | $466,125 | September 1, 2022 | August 31, 2025 | CARDOZO, TIMOTHY J | reporter.nih.gov |
| (PQ#9) Promoting Axon Stability to Prevent Therapy-induced Peripheral Neuropathy | NIH | National Cancer Institute | 2021 | $465,400 | August 16, 2017 | July 31, 2022 | DIANTONIO, AARON | reporter.nih.gov |
| Harnessing T-junction filtering; bidirectional control of sensory neuron impulse traffic | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $462,331 | September 15, 2017 | July 31, 2023 | HOGAN, QUINN H | reporter.nih.gov |
| In-vivo Assessment of Neuroinflammation in Painful Trigeminal Neuropathy | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2024 | $462,000 | June 1, 2023 | May 31, 2026 | LOGGIA, MARCO LUCIANO | reporter.nih.gov |
| Neuroprotection for chemotherapy induced peripheral neuropathy | NIH | National Cancer Institute | 2024 | $462,000 | March 1, 2024 | February 28, 2027 | YANG, IN HONG | reporter.nih.gov |
| Investigating Peripheral Neuropathy in Spinocerebellar Ataxia Type 3 | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $460,643 | August 1, 2025 | July 31, 2030 | MCLOUGHLIN, HAYLEY S | reporter.nih.gov |
| Bioengineering a human microphysiological system for elucidation of viral peripheral neurotropism of RSV and SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $457,778 | September 5, 2025 | August 31, 2027 | MOORE, MICHAEL J | reporter.nih.gov |
| Discovery of NaV1.7 Inhibitors for the Treatment of Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $455,622 | May 15, 2021 | April 30, 2022 | MULCAHY, JOHN VINCENT | reporter.nih.gov |
| PPAR inhibition of spinal pain transmission | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $455,478 | December 18, 2008 | January 31, 2024 | TAYLOR, BRADLEY K. | reporter.nih.gov |
| Discovery and development of novel glycine transporter-2 inhibitors for the treatment of neuropathic pain | NIH | National Institute on Drug Abuse | 2022 | $455,166 | July 1, 2022 | June 30, 2025 | CIOFFI, CHRISTOPHER L. | reporter.nih.gov |
| Mechanisms of Peripheral Nerve Injury and Recovery in a Zebrafish Demyelination Model | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $454,424 | April 1, 2025 | March 31, 2028 | PETERSEN, SARAH | reporter.nih.gov |
| Role of Cathepsin S in Dry Eye Associated Neuropathic Pain | NIH | National Eye Institute | 2022 to 2023 | $453,750 | August 1, 2022 | July 31, 2025 | EDMAN, MARIA C | reporter.nih.gov |
| Functional role of satellite glial cells in axon regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $453,651 | December 1, 2019 | November 30, 2022 | CAVALLI, VALERIA | reporter.nih.gov |
| Analysis of ascending spinal pain circuits | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $453,104 | February 1, 2025 | November 30, 2029 | CHOI, SEUNGWON | reporter.nih.gov |
| Ectopic Olfactory Receptor Guided Facial Nerve Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2023 | $453,071 | September 1, 2023 | August 31, 2025 | SAKIYAMA-ELBERT, SHELLY ELESE | reporter.nih.gov |
| A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy | NIH | National Cancer Institute | 2022 | $452,540 | September 23, 2022 | August 31, 2025 | LEE, RICHARD T | reporter.nih.gov |
| MIXED NOP/MU COMPOUNDS AND THE INVOLVEMENT OF THEIR RECEPTORS IN ANALGESIA | NIH | National Institute on Drug Abuse | 2021 | $452,403 | July 1, 2018 | June 30, 2024 | TOLL, LAWRENCE R | reporter.nih.gov |
| The impact of ITPR3 mutations on immunity | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $451,000 | June 21, 2024 | April 30, 2027 | VAN OERS, NICOLAI STANISLAS CYRILLE | reporter.nih.gov |
| Diabetic skin influences on outgrowth of human iPSC-derived sensory axons | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $450,313 | July 1, 2022 | June 30, 2024 | FARAH, MOHAMED H | reporter.nih.gov |
| Developing macrophage-based therapies for peripheral nerve injuries | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $450,313 | July 1, 2023 | June 30, 2025 | MORRISON, BRETT M. | reporter.nih.gov |
| MAP4K4 inhibition to prevent CIPN | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $450,313 | June 21, 2024 | May 31, 2026 | HOKE, AHMET | reporter.nih.gov |
| Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment? | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $447,525 | April 1, 2019 | April 30, 2024 | SALOMAN, JAMI LYNN | reporter.nih.gov |
| Regulation of Neuroinflammation after Peripheral Nerve Injury | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $447,000 | May 17, 2023 | April 30, 2026 | ROOSSIEN, DOUGLAS HOWARD | reporter.nih.gov |
| Genetic and physiological comparison of native human sensory neurons and induced pluripotent stem cells differentiated to sensory neurons | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $445,500 | September 8, 2022 | August 31, 2025 | BERTA, TEMUGIN | reporter.nih.gov |
| Supplement to Support the Acquisition of a High-Precision 3D Printer | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $445,118 | August 5, 2025 | November 30, 2025 | KUMBAR, SANGAMESH GURAPPA | reporter.nih.gov |
| STING & PAIN: exploring a viral signaling protein in nociception and neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $445,031 | April 15, 2021 | October 14, 2023 | BERTA, TEMUGIN | reporter.nih.gov |
| Mechanisms of Varicella Zoster Virus Latency in Human Sensory Neurons | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $444,172 | January 24, 2024 | November 30, 2025 | VENKATESAN, ARUN | reporter.nih.gov |
| Exploring the unknown function of LRRC55 in pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $444,125 | September 19, 2024 | August 31, 2026 | YANG, HUANGHE | reporter.nih.gov |
| AIBP and regulation of neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $443,771 | August 15, 2017 | May 31, 2023 | MILLER, YURY | reporter.nih.gov |
| Characterizing Tissue Specific Regulation of Mutant Lamin Protein Degradation | NIH | National Institute on Aging | 2021 | $442,936 | July 1, 2016 | August 30, 2025 | HAMMOND, THOMAS MICHAEL | reporter.nih.gov |
| The integration of laboratory data with computational 3-D modeling to analyze the role of the central amygdala in neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $441,500 | September 7, 2023 | August 31, 2026 | MILLER NEILAN, RACHAEL | reporter.nih.gov |
| SARM1-mediated mechanisms of axon degeneration | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $441,195 | August 1, 2025 | April 30, 2030 | FREEMAN, MARC R | reporter.nih.gov |
| Biomarkers for prognosis of closed-mechanism nerve injuries | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $440,604 | June 1, 2023 | May 31, 2025 | MAHAN, MARK | reporter.nih.gov |
| Cholinergic modulation of Descending Pain Control Pathways | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $438,712 | August 1, 2021 | January 31, 2023 | MCGEHEE, DANIEL S | reporter.nih.gov |
| Regulation of microglia-mediated neuroinflammation by store operated Orai1 channels | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $438,473 | April 1, 2021 | September 30, 2023 | PRAKRIYA, MURALI | reporter.nih.gov |
| Development of optoelectronically active nerve adhesive for accelerating peripheral nerve repair | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $437,331 | September 22, 2023 | August 31, 2025 | DUAN, BIN | reporter.nih.gov |
| Cellular senescence in chronic pain and aging | NIH | National Institute on Aging | 2022 to 2023 | $437,254 | August 1, 2022 | October 31, 2024 | TAWFIK, VIVIANNE L | reporter.nih.gov |
| Targeting TRPV1-containing nerves for radiation-induced pain and oral mucositis | NIH | National Institute of Dental & Craniofacial Research | 2024 to 2025 | $437,250 | July 1, 2024 | June 30, 2026 | SCHEFF, NICOLE N | reporter.nih.gov |
| Molecular analysis of the blood-nerve barrier in health and diabetes | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $437,250 | September 20, 2024 | August 31, 2026 | DANEMAN, RICHARD | reporter.nih.gov |
| The role of a lysosomal mechano-sensitive ion channel in pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $435,875 | September 28, 2022 | August 31, 2025 | FEHRENBACHER, JILL C | reporter.nih.gov |
| Targeting the PMP22 Protein to Develop Leads Against Charcot-Marie-Tooth Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $435,441 | January 20, 2021 | December 31, 2022 | SANDERS, CHARLES R | reporter.nih.gov |
| Mechanistic Studies of the Natural Product Nicotinamide Riboside for Relief of Painful Sensory Neuropathy | NIH | National Center for Complementary & Integrative Health | 2021 | $435,244 | February 1, 2018 | July 31, 2022 | HAMMOND, DONNA L | reporter.nih.gov |
| Microscopic Robot-Assisted Axon Regrowth for Rapid Repair of Peripheral Nerve Injuries | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2023 | $434,868 | September 1, 2022 | June 30, 2024 | MISKIN, MARC | reporter.nih.gov |
| Regulation of Schwann Cell Mitochondria Homeostasis in Painful Peripheral Neuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $434,500 | September 18, 2023 | August 31, 2025 | CAMPANA, WENDY M. | reporter.nih.gov |
| Kratom and Cannabinoid Constituents: Mechanisms and Interactive Effects in Neuropathic Pain | NIH | National Center for Complementary & Integrative Health | 2023 | $433,710 | August 7, 2023 | July 31, 2025 | WARD, SARA J | reporter.nih.gov |
| Near Infrared Light Activated Adhesives for Nerve Repair | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $433,666 | June 23, 2021 | April 30, 2024 | REGE, KAUSHAL | reporter.nih.gov |
| Translational profiling of bladder sensory nerves and their cell type identities using dissociation free single nucleus sequencing | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $433,125 | August 1, 2021 | June 30, 2025 | JAIN, SANJAY | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston, MA | 16 | $39.3 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 28 | $28.7 million | 0 | $0 |
| Washington University | Saint Louis, MO | 29 | $25.4 million | 0 | $0 |
| Stanford University | Stanford, CA | 15 | $21.8 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 17 | $18.4 million | 0 | $0 |
| University of Texas at Dallas | Richardson, TX | 8 | $18.4 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 20 | $16.1 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 5 | $14.1 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 18 | $13.6 million | 0 | $0 |
| Ohio State University | Columbus, OH | 13 | $12.5 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 12 | $12.3 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 5 | $12.2 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 8 | $11.7 million | 0 | $0 |
| University of Rochester | Rochester, NY | 10 | $11.4 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 5 | $11.4 million | 0 | $0 |
| Duke University | Durham, NC | 8 | $11.2 million | 0 | $0 |
| Marine Biological Laboratory | Woods Hole, MA | 1 | $11.2 million | 0 | $0 |
| Emory University | Atlanta, GA | 10 | $10.5 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 7 | $9.6 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 9 | $9.5 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 15 | $9.4 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 3 | $8.8 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 10 | $8.5 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 8 | $8.4 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 6 | $8.3 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 8 | $8.3 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 5 | $8.2 million | 0 | $0 |
| Yale University | New Haven, CT | 7 | $8 million | 0 | $0 |
| New York University | New York, NY | 9 | $8 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 11 | $8 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 6 | $7.8 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 10 | $7.6 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 6 | $7.6 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 10 | $7.3 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 5 | $7.3 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 7 | $7 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 5 | $6.6 million | 0 | $0 |
| University of New England | Biddeford, ME | 7 | $6.6 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 4 | $6.5 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 5 | $6.2 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 4 | $6.2 million | 0 | $0 |
| University of Vermont & ST Agric College | Burlington, VT | 1 | $6.1 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 7 | $6.1 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 5 | $6.1 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 6 | $5.9 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 4 | $5.9 million | 0 | $0 |
| Siteone Therapeutics, Inc. | South San Francisco, CA | 2 | $5.8 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 5 | $5.8 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 6 | $5.8 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 5 | $5.7 million | 0 | $0 |
| Micro-Leads, Inc. | Somerville, MA | 2 | $5.6 million | 0 | $0 |
| 4e Therapeutics Inc. | Austin, TX | 1 | $5.6 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 7 | $5.4 million | 0 | $0 |
| University of Washington | Seattle, WA | 5 | $5.2 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 3 | $5.1 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 4 | $5 million | 0 | $0 |
| Saint Louis University | Saint Louis, MO | 4 | $5 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 3 | $4.9 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 3 | $4.8 million | 0 | $0 |
| Eicosis, LLC | Davis, CA | 1 | $4.6 million | 0 | $0 |
| University of California at Davis | Davis, CA | 4 | $4.6 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 6 | $4.6 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 3 | $4.5 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 5 | $4 million | 0 | $0 |
| Afasci, Inc. | Redwood City, CA | 2 | $4 million | 0 | $0 |
| Mitochondria in Motion, Inc. | Saint Louis, MO | 3 | $4 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 6 | $4 million | 0 | $0 |
| Axonova Medical, LLC | Philadelphia, PA | 3 | $4 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 6 | $3.8 million | 0 | $0 |
| Spaulding Rehabilitation Hospital | Charlestown, MA | 3 | $3.6 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 2 | $3.6 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 2 | $3.5 million | 0 | $0 |
| Texas Tech University Health Scis Center | Lubbock, TX | 5 | $3.5 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 6 | $3.3 million | 0 | $0 |
| Anagin | Indianapolis, IN | 1 | $3.3 million | 0 | $0 |
| Visionquest Biomedical INC | Albuquerque, NM | 3 | $3.2 million | 0 | $0 |
| Navega Therapeutics, Inc. | San Diego, CA | 4 | $3.2 million | 0 | $0 |
| Queen's Medical Center | Honolulu, HI | 1 | $3.2 million | 0 | $0 |
| Sparian Biosciences, Inc. | New York City, NY | 1 | $3.1 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 3 | $3.1 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 3 | $3 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 8 | $3 million | 0 | $0 |
| Albany Medical College | Albany, NY | 4 | $3 million | 0 | $0 |
| Creative Bio-Peptides, Inc. | Potomac, MD | 1 | $3 million | 0 | $0 |
| Winsantor, Inc. | San Diego, CA | 2 | $3 million | 0 | $0 |
| Kannalife Sciences, Inc. | Lloyd Harbor, NY | 1 | $3 million | 0 | $0 |
| Brown University | Providence, RI | 2 | $2.9 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 3 | $2.8 million | 0 | $0 |
| Wayne State University | Detroit, MI | 4 | $2.8 million | 0 | $0 |
| Raft Pharmaceuticals, LLC | San Diego, CA | 2 | $2.7 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 5 | $2.7 million | 0 | $0 |
| University of Rhode Island | Kingston, RI | 1 | $2.7 million | 0 | $0 |
| Highland Instruments, Inc. | Cambridge, MA | 3 | $2.7 million | 0 | $0 |
| Apt Therapeutics, Inc. | Naperville, IL | 2 | $2.7 million | 0 | $0 |
| Georgia State University | Atlanta, GA | 3 | $2.7 million | 0 | $0 |
| University of Chicago | Chicago, IL | 3 | $2.6 million | 0 | $0 |
| Auxilium Biotechnologies Inc. | San Diego, CA | 1 | $2.6 million | 0 | $0 |
| Northwestern University | Chicago, IL | 2 | $2.5 million | 0 | $0 |
| University of Florida | Gainesville, FL | 5 | $2.5 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 4 | $2.5 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 291 | $160,321,050 | 0 | $0 |
| 2024 | 306 | $159,985,825 | 0 | $0 |
| 2023 | 343 | $187,322,048 | 0 | $0 |
| 2022 | 357 | $162,938,130 | 0 | $0 |
| 2021 | 342 | $174,382,023 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.